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Abstract
Aim: To describe innovative uses of catheter based treatment in a variety of native and 
post surgical stenoses in children and young adults with congenital heart disease.
Background: Cardiac catheterization in man was first described 1929 and since then 
there has been a drive to develop endovascular techniques to investigate and treat both 
congenital and acquired heart disease. Many of the advances are being made in 
congenital heart disease.
Methods: A number of congenital cardiac stenotic lesions were studied including baffle 
obstruction after atrial switch for transposition of the great arteries, aortic stenosis in 
infants, coarctation of the aorta, peripheral pulmonary artery stenosis and superior vena 
caval obstruction. The use of angioplasty balloons, cutting balloons, stents and 
alternative catheter approaches were investigated for these lesions. 
Results: Following atrial redirection surgery for transposition of the great arteries 
balloon angioplasty improved baffle haemodynamics. The technique of anterograde 
balloon dilation of the aortic valve was developed and had superior outcomes in terms 
of aortic insufficiency compared to a retrograde approach in neonates with severe aortic 
valve stenosis. In an animal model of peripheral pulmonary arterial stenosis, the 
application of cutting balloon angioplasty produced effective relief in a controlled 
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fashion. Balloon mounted stents were used in patients with native and post surgical 
coarctation of the aorta with significant relief of stenosis and relief of hypertension. 
Finally, a group of patients with superior vena obstruction syndrome after surgical 
repair of partial anomalous pulmonary venous drainage had successful treatment using 
balloon mounted stents.
Conclusions: Catheter based treatment of congenital and post surgical vascular stenoses 
of the heart and great arteries using angioplasty balloons, cutting balloons and balloon 
mounted stents is safe and appears to be effective in the short and medium term. It may 
represent a useful alternative to surgery and will reduce the number of surgical 
procedures required over a lifetime. Future directions will include bio-absorbable stents 
and hybrid techniques involving surgery.
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Lay summary
Congenital heart disease is the commonest birth abnormality with an incidence of 8 per 
1000 live births. There is a wide spectrum of disease and in the majority of children the 
heart is the only organ affected. About half of these children will need treatment to 
correct or at least lessen the physical impact of their condition. In most cases, it is the 
structure of the heart which is affected and therefore treatment has to be in the form of 
an operation or in some children a series of operations which may extend over the 
individuals lifetime. In order to reduce the impact of surgery, which can be particularly 
significant in young babies, non surgical alternative treatments using cardiac catheter 
techniques are being developed. These techniques involve entry into the circulation 
usually via the artery and vein at the top of the leg followed by treating the defect in the 
heart or the great vessels close to the heart from the inside as opposed to treating from 
the outside which is what happens during surgery. The heart is reached by long fine 
plastic tubes called catheters supported by fine guide wires and the abnormality is 
addressed using different types of inflatable balloons and devices which are mounted at 
the ends of catheters or guide wires. 
This thesis describes innovations in the use of catheter mounted balloons and particular 
devices called stents, which support vessel walls, to treat of a number of either native or 
post surgical obstructions within the heart or great vessels in children and adults 
affected by congenital heart disease. It also addresses how the application of this 
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technology can complement heart surgery, reduce the number of operations required 
over a lifetime and how it might develop in the future.
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Surgery. Performing procedures on the heart and great vessels has traditionally carried a 
degree of dread because of the vital nature of these structures. At the end of the 19th 
century, surgery on the heart was considered beyond the natural limits of medicine. The 
influential German surgeon Theodor Billroth, who pioneered abdominal surgery, stated 
in 1883 "A surgeon who tries to suture a heart wound deserves to lose the esteem of his 
colleagues." In 1896, the surgeon Stephen Paget writing in his textbook on surgery of 
the chest stated, “Surgery of the heart has probably reached the limit set by nature to all 
surgery; no new method and no new discovery can overcome the natural difficulties that 
attend a wound of the heart”. Nevertheless it was in that same year that the first 
successful operation on the heart was performed by Ludwig Rehn (1897) in Frankfurt 
when he repaired a stab wound to the right ventricle sustained by a wounded soldier and 
in doing so completely changed attitudes towards cardiac surgery.
The next landmark was the first surgical treatment of valvular heart disease which was 
performed in 1925 by the British surgeon Henry Sessions Souttar (1925) when he 
dilated a mitral valve using his finger inserted through an opening made in the left atrial 
appendage and in doing so saved the life of a young girl with severe rheumatic mitral 
stenosis. At the time, the procedure was heavily criticized by the medical community 
because of the perceived risk and was not repeated until 1948. Surgery for valvular 
heart disease only really began after the second world war the with the efforts of 
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surgeons such as Dwight Harken (1946) based on their experience as US Army 
surgeons. He had removed foreign bodies from in and around the hearts of over 100 
soldiers who had been wounded in battle and his experience greatly increased to 
confidence of surgeons to undertake operations on the heart (Harken et al., 1948).
 
Although much less common than acquired heart disease, the really big breakthroughs 
in cardiac surgery were made in the treatment of congenital heart disease. Back in 1907, 
John Munro of Boston had proposed surgical treatment of the patent arterial duct 
through the sternum and was able to demonstrate technical feasibility by operating on 
the cadavers of 2 neonates, however he did not attempt the surgery in a living child. 
This fell to Robert Gross at Boston Children’s Hospital who in 1938 reported the first 
successful ligation of a patent arterial duct between the descending aorta and left 
pulmonary artery via a left thoracotomy (Gross and Hubbard, 1939). It has since come 
to light than the first successful surgical ligation of a patent arterial duct had actually 
been performed earlier in the same year by Emil Karl Frey a surgeon in Dusseldorf 
(Kaemmerer et al., 2004). Frey had neglected to report his procedure probably on the 
assumption that it would be the first of many. 
Only a few years later in 1944 saw the transformational Blalock-Taussig shunt carried 
out at Johns Hopkins Hospital to augment pulmonary blood flow in an infant with 
severe tetralogy of Fallot. This procedure was based on the collaboration between the 
surgeon Alfred Blalock and the cardiologist Helen Taussig (Blalock and Taussig, 1945). 
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It was only later recognized that much of the credit was due to the work of Vivien 
Thomas, Blalock’s surgical assistant., who had developed the technique by operating on 
dogs in the laboratory. The classical Blalock-Taussig shunt involved division of the 
subclavian artery and anastomosis end to side onto the ipsilateral branch pulmonary 
artery in order to augment pulmonary blood flow (Fig. 1). 
Figure 1. The classical Blalock-Taussig Shunt. Illustration from: The surgical treatment of 
malformations of the heart in which there is pulmonary stenosis or pulmonary atresia. (1945)
Journal of the American Medical Association,128,189-202. 
!
In the same year came the report of the first repair of coarctation of the aorta by 
Crafoord and Nyhlin (1945) in Sweden using the technique of resection with end to end 
anastomosis (Fig. 2). Crafoord had been safely cross clamping the aorta for short 
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periods while performing duct ligation and extended this application to coarctation 
repair by placing 2 clamps on either side of the obstruction before resecting the 
narrowed portion.
Figure 2. Resection and end to end anastomosis of coarctation of the aorta, as described by 
Crafoord and Nyhlin.
 
There remained the significant challenge of opening and operating on the beating heart 
itself. In 1950, Bigelow in Toronto reported the experimental use of surface 
hypothermia (Bigelow, Lindsay and Greenwood, 1950) and in 1952 John Lewis, at the 
University of Minnesota, used hypothermia to around 260 C to slow the heart 
sufficiently to allow repair of an atrial septal defect under direct vision in a 5 year old 
girl (Lewis and Taufic, 1953). To secure a bloodless field snares were placed around the 
inferior and superior vena cavae. Although this method did not gain popularity, it did 
stimulate progress and the further development of hypothermia and cardiopulmonary 
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bypass. Hypothermia itself provided only a small window of time in the order of 10 
minutes to allow surgery on the heart before irreversible cerebral ischaemia would 
occur. While others such as Gibbon were working on membrane oxygenation (Gibbon, 
1954), C. Walt Lillehei, who was part of Lewis’s team at Minnesota, developed the 
technique of cross circulation where a donor, who was usually a parent, would provide 
oxygenated arterial blood to the infant being operated on via a pump (Fig. 3). The first 
patient was a 13 month old with a ventricular septal defect and although the operation 
was a success, the child died 11 days later with suspected pneumonia. During the next 
year, 44 open heart procedures were performed in this manner with 32 survivors 
(Lillehei et al., 1955) Lillehei himself said that it was the only operation with a 
potentially 200% mortality however only one donor suffered a significant complication, 
a stroke probably caused by air embolism.
Once the problem of cardiopulmonary bypass was resolved progress in cardiac surgery 
was rapid with the first coronary artery bypass graft performed in New York in 1960 
(Konstantinov, 2000), the first mitral valve replacements in the same year (Braunwald, 
Cooper and Morrow, 1960) and of course the first heart transplant in 1967 (South 
African Medical Journal, 1967).
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Figure 3.  Schematic illustration of the first case of controlled cross circulation, 1954. Original 
drawing made by the intern on C. Walton Lilleheiʼs service, GOTT V.L. (1994) Section III: 
Cardiopulmonary bypass and myocardial protection. IN: STEPHENSON L.W., RUGGERO R., 
(Eds). Heart surgery classics, Boston: Adams Publishing Group, Ltd,130.
Catheterization. As well as looking at the problem of the heart from the outside, others 
were finding ways to access the heart via the circulation for diagnostic purposes and 
potentially treatment. The first cardiac catheterization was credited to Stephen Hales 
(Lewis, 1994), an English clergyman who in 1733 cannulated the aorta of a horse using 
an instrument made of brass pipes, a glass tube and the trachea of a goose enabling him 
to directly measure systemic arterial pressure. In 1929, a German surgical trainee named 
Werner Forssman inserted a ureteric catheter into his own antecubital vein, advanced it 
under fluroscopy and then walked along a corridor and up two flights of stairs before 
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having a chest X-ray (Fig. 4) confirming the tip of the catheter to be in the right atrium 
(Forssmann, 1929). Once he published his findings, he was strongly condemned by his 
university for self experimentation and went into urology instead of cardiology but 
eventually achieved recognition when he jointly won the Nobel prize for Medicine in 
1956. 
Figure 4. The Chest X-Ray of Dr Werner Forssman showing the catheter advanced from the left 
ante-cubital vein and lying with the tip within the right atrium. 
In the 1940s, Andre Cournand and Dickinson Richards developed cardiac 
catheterization and used it to investigate right heart physiology. They subsequently 
shared the Nobel prize with Forssman in 1956. Retrograde left heart catheterization was 
first described by Zimmerman, Scott and Becker (1950) and selective coronary 
angiography was reported by Mason Sones (1959) after he accidentally selectively 
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entered the right coronary artery during a power injection of contrast into the aortic root 
in a 26 year old with rheumatic heart disease. 
!
A non-surgical or minimally invasive approach to the treatment as well as diagnosis of 
many conditions is always an attractive option as there are obvious benefits in terms of 
a reduction in the amount of discomfort, the time spent in hospital, the risk of infection 
and the size of a surgical scar. This is all providing the approach can be as safe and 
effective as surgery. The case for using catheter based techniques for treatment as well 
as diagnosis in children is perhaps even more attractive as the prospect of surgery on the 
heart and great vessels can seem daunting to families. In addition for a sick child a 
catheter based treatment as either palliation or definitive treatment might be a safer 
option. Over the past 5 decades, surgery for congenital heart disease has improved 
markedly in terms of efficacy and safety however in the earlier decades the high risk of 
surgery was probably an added stimulus for the development of non surgical techniques 
in some centres. One further incentive to non surgical treatment is the fact that 
congenital heart disease is often a life long condition with the need for multiple re-
interventions. It would be an advantage if some of these can be preformed in a manner 
that reduces the tissue trauma and catabolic load to the individual which in turn would 
mean a shorter recovery time. The first report of catheter based treatment of congenital 
heart disease was by Rubio-Alvarez and his colleagues in Mexico City in 1953 who 
described the use of a cutting wire mounted at the end of a ureteric catheter introduced 
via the femoral vein to relieve pulmonary stenosis in 3 patients (Rubio-Alvarez, Limon 
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and Soni, 1953). Cardiac surgery was still in its infancy, this was in the era before 
cardiopulmonary bypass and the only surgical treatment available for pulmonary valve 
stenosis was closed pulmonary valvotomy first described by Thomas Holmes Sellor
(1948) and then independently by Lord Brock. In this procedure, which has become 
known as the Brock procedure (Fig. 5), the heart was exposed via a sternotomy and the 
main pulmonary artery entered using a trocar introduced through a controlling suture. A 
valvulotome (instrument for cutting a valve) was then inserted into the pulmonary artery  
and 2 valvulotomies were made in the region of the anterior 2 commissures of the valve 
in order to avoid the coronary arteries lying posteriorly. 
Figure 5. Diagram of transventricular pulmonary valvotomy developed by Sellors and Brock.
The technique developed by Rubio-Alvarez was an attempt to replicate this via an 
endovascular approach. The tip of a ureteric catheter was pre-shaped into a bend and 
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the wire kept straight allowing it to ‘saw’ through the fused commissures of the valve 
(Fig. 6). The procedure was first performed in a 10 month old child with severe 
pulmonary valve stenosis and produced a reduction in the invasive peak systolic 
pressure gradient across the valve from 72-59 mmHg. Although successful, the 
technique was challenging and hazardous and was only used in a few patients. 
Unsurprisingly, it did not gain acceptance and was not attempted by other operators. 
Figure 6. Illustration of the first successful transcatheter valvotomy by Rubio-Alvarez (from 
Arch. Institut. Cardiol. Mexico 1953).
At around the same time, guidewires were being developed and in 1953 Sven-Ivar 
Seldinger, a radiologist, described a unique method of establishing vascular access 
using a guidewire (Fig. 7) making interventional radiology and subsequently 
interventional cardiology a realistic possibility (Seldinger, 1953). Continued 
development of materials science especially of plastics and their formation into 
catheters by extrusion techniques made a huge contribution to progress. The concept of 
a sheath, which is a smaller indwelling catheter in the vessel often with a sidearm to 
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allow flushing, allowing easy exchanges of catheters and guidewires greatly contributed 
to the ease of which endovascular techniques could be performed.
Figure 7. Reproduction of the original illustration from SELDINGER S.I. (1953) Catheter 
Replacement of the Needle in Percutaneous Arteriography: A new technique. Acta Radiologica, 
39(5), 368-376.
No further reported attempts were made to treat congenital heart disease using non 
surgical approaches until the pioneering work by the cardiologist William Rashkind at 
Johns Hopkins Hospital, Baltimore in 1965 (Rashkind and Miller, 1966). By this stage 
cardiopulmonary bypass had been developed and one major success story in congenital 
heart disease was the surgical treatment of transposition of the great arteries (Fig. 8). In 
this condition, the pulmonary artery and aorta are wrongly connected to the two 
ventricles meaning that de-oxygenated blood is pumped back into the systemic 
circulation. Prior to 1959, the prognosis for this condition was so poor that few babies 
survived until the end of the first year of life.
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Figure 8. Diagram of the normal heart and a heart with transposition of the great arteries. 
Then in 1959, Senning in Sweden described the atrial switch procedure which allowed 
redirection of the systemic and pulmonary venous inflow to the heart using flaps 
constructed from the right atrial wall and interatrial septum (Senning, 1959). Successful 
anatomical correction did not come for many years because of the technical difficulties 
of transferring the coronary arteries. Senning’s technique meant that 2 circulations in 
parallel were converted into 2 in series. This was followed by the technically less 
demanding Mustard procedure in 1963 developed by William Mustard, who originally 
trained as an orthopaedic surgeon and was working at the Hospital for Sick Children in 
Toronto (Mustard et al., 1964). This procedure used patches of either pericardium or 
synthetic material to baffle the venous inflows and in doing so redirect the blood. 
However, these atrial switch procedures could not be performed at birth and therefore 
palliation to allow some mixing of the circulations was necessary to buy time unless an 
atrial or ventricular septal communication already existed. This palliation took 
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the form of the Blalock-Hanlon septectomy (Fig. 9), first described in 1950, where the 
surgeon excised the posterior aspect of the atrial septum via a right lateral thoracotomy 
so allowing blood to mix at atrial level and improve tissue oxygen delivery (Blalock and 
Hanlon, 1950).
Figure 9. Illustration of Blalock-Hanlon sepectomy with specifically designed side biting clamp 
used to isolate part of right atrium allowing the surgeon to excise atrial septum.
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Figure 10. Still image of balloon atrial septostomy under fluoroscopic control in a neonate with 
transposition of the great arteries. The balloon filled with dilute contrast material is being 
withdrawn from the left to the right atrium in order to tear open the septum. 
What Rashkind did was to replace the Blalock Hanlon procedure with an endovascular 
technique which could be performed via either the femoral or umbilical veins in 
newborn babies with transposition. This was a much less traumatic procedure than 
surgical septectomy especially in those sick neonates with profound desaturation 
because of a very restrictive interatrial communication. A balloon tipped catheter was 
advanced from the inferior vena cava across the patent foramen ovale into the left 
atrium, the balloon was then filled with dilute contrast agent and then abruptly pulled 
back under fluoroscopy X-ray guidance to tear open the fossa ovalis so creating mixing 
of the circulations (Fig. 10). This was a truly revolutionary technique and represented 
15
the beginning of catheter based treatment for congenital heart disease inspiring many 
others to think along these lines. 
“...The initial response to this report varied between admiration and horror but, 
in either case, the procedure stirred the imagination of the “invasive” 
cardiologists throughout the entire cardiology world and set the stage for all 
future intracardiac interventional procedures – the true beginning of pediatric 
and adult interventional cardiology.” (Charles E. Mullins, 1998)
The next attempt to use a catheter in the treatment of congenital heart disease was by 
Semb in Sweden (Semb et al.,1979). Using the same concept as Rashkind, he used a 
Berman Angiographic Catheter with the balloon filled with carbon dioxide to relieve 
pulmonary stenosis by rapidly withdrawing it across the valve and in doing so tearing 
fused valve commissures. This was a particularly interesting neonate with the 
haemodynamically adverse combination of severe pulmonary valvar stenosis and severe 
tricuspid insufficiency. The baby was thought to be too unwell to undergo cardiac 
surgery and instead underwent this dynamic balloon dilation of the pulmonary valve. 
The result was excellent with effective relief of stenosis and only mild residual tricuspid 
regurgitation when the pressure load was relieved. However, similarly to the experience 
of Rubio-Avarez, this technique was not adopted for general use because of the 
unpredictability of the outcome and the fact that the valve leaflets could be completely 
avulsed producing free regurgitation.  
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Figure 11. Angiograms before, immediately after and 6 months after angioplasty of the popliteal 
artery in an 82 year old patient with gangrene taken by Charles Dotter. 
To understand the next step forward in catheter based treatment it is necessary to go 
back in time to 1963 when a radiologist named Charles Dotter accidentally recanalized 
a blocked iliac artery during an attempt to perform an aortogram in a patient with renal 
artery stenosis. Based on this experience he conceived the idea of sequential dilators for 
arterial stenoses. Their first successful use was in an 82 year old woman suffering from 
gangrene due to popliteal arterial stenosis (Fig. 11) who had refused amputation (Dotter 
and Judkins, 1964). It was Andreas Gruentzig, working in Zurich, who took this 
technology further by using balloons instead of dilators. The balloons were mounted at 
the end of double lumen catheters with one lumen for the supporting guide-wire and the 
other to allow inflation. The concept was different from that of Rashkind as the balloons 
were held in a static position during inflation and deflation instead of being abruptly 
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withdrawn to tear a structure. A number of different materials were tried for the balloon 
before polyvinyl chloride was chosen for it’s non elastic properties. Greuntzig went on 
to use this system to dilate stenotic lesions in experimental animals and humans with 
peripheral vascular disease. In September 1977, he performed the first coronary 
angioplasty in a 37 year old man in Switzerland (Greuntzig, 1978) which heralded the 
era of coronary intervention for ischaemic heart disease.
Following on from the experience in peripheral and coronary arteries, it was only a 
matter of time before static balloon angioplasty was applied to congenital lesions. In 
1982 Dr Jean Kan, also at Johns Hopkins, performed successful balloon dilation of the 
pulmonary valve in a 6 year old girl with pulmonary stenosis (Kan et al., 1982). Since 
then, balloon angioplasty (Fig. 12) became the treatment of choice for valvar pulmonary 
stenosis (Stanger at al., 1990) and was soon applied to the aortic valve in children 
(Lababidi, Wu and Walls, 1984).
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Figure 12. Lateral angiogram of balloon dilation of the pulmonary valve. The left hand panel 
shows a doming pulmonary valve with post stenotic dilatation of the pulmonary arteries, the 
right hand panel shows the balloon being inflated across the valve. 
The mechanism of success of angioplasty must involve partial tearing of vascular 
structures either of valve commissures or vessel stenoses and as such it could be 
considered to be relatively uncontrolled when compared to surgery where there is the 
advantage of direct inspection. Potential complications of angioplasty could include 
complete vessel tears, false or true aneurysm formation and avulsion of valve leaflets as 
well as damage to sites of vascular access. In addition, elastic, kinked and non-discrete 
lesions may not respond as the improvement in diameter will not be maintained once 
the balloon is deflated. A vessel which is narrow over some distance might not be 
expected to respond favourably to angioplasty and overinflation of a balloon in this 
situation could lead to a longitudinal partial or complete vessel tears. In the situation of 
valvar stenosis, the tearing has to be along the congenitally fused valve commissures to 
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relieve stenosis without tearing through or avulsing the leaflets and thus causing 
significant regurgitation (Hawkins et al., 1995). If this were to occur, there is no way for 
the operator to acutely undo the damage which must be repaired surgically with the 
timing of surgical intervention depending on severity. Severe regurgitation of the aortic, 
mitral or tricuspid valve is poorly tolerated especially when the onset is acute.  
In order to overcome recoil after angioplasty, some means has to be found to maintain 
support of the vessel walls using a device which is safe to use in prolonged contact with 
the bloodstream. Supporting a dilated vessel may also effectively treat long segment 
stenosis and reduce the risks of tearing or aneurysm formation. It could also be used to 
treat aneurysms by strengthening the wall so preventing further expansion. Again it was 
Dotter (1969) who came up with the original concept of supporting vessels when he 
published a technique to place endovascular spiral stents and proposed the use of such 
structures to treat aneurysms. Then in the early 1980s, Maass working at the surgical 
clinic of the University of Zurich, developed a double helix spiral prosthesis from self 
expanding spring coils which he used in animal experiments and eventually in 2 patients 
with dissecting aortic aneurysms-the first time that vascular stents were used in humans 
(Maass et al., 1984). These spring coils worked by decreasing in diameter when torque 
was applied and expanding to their original diameter when it was released. 
Incorporation of the stent into the vessel wall, so called endothelialisation, took around 
3 weeks in animal experiments. Balloon expandable stents were invented by Julio 
Palmaz, a Argentinian vascular radiologist, who initially reported their use in the aortae 
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and peripheral arteries of dogs (Palmaz et al., 1985). These systems consisted of 
stainless steel grafts mounted onto and expanded by angioplasty balloons and were 
extensively used to treat peripheral vascular disease. 
Figure 13. Spiral spring stents, single and double helex developed by Maass for endovascular 
implantation.
With increasing confidence in peripheral vascular stenting, the technique was then 
applied to the coronary arteries. The first coronary stent was implanted by Puel in 
Toulouse and shortly afterwards by Ulrich Sigwart in Lausanne in 1986 using self 
expanding Medinvent stents which became known as Wallstents. 
They subsequently reporting their findings of the use of these stents to prevent vessel 
reocclusion after coronary artery angioplasty (Sigwart et al.,1987). A little later Palmaz 
teamed up with the cardiologist Richard Schatz and developed the balloon expandable 
Palmaz-Schatz stent for coronary use (Schatz et al., 1987).
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In general, self expanding stents such as the Wallstent and stent grafts have less radial 
strength and are more suited to excluding aneurysms rather than dilating and supporting 
stenotic vessels. In children and adults with congenital heart disease, the main aim is to 
keep vessels open rather than to exclude aneurysms. After animal experiments to 
investigate the feasibility of Palmaz stent implantation in pulmonary arteries and 
systemic veins, the first balloon expandable stents were implanted in a child with 
stenosis of the branch pulmonary arteries in 1989 by Mullins using Palmaz stents 
originally designed for peripheral vascular disease in the iliac arteries (O’Laughlin et 
al., 1991). Since then stents have found increasing applications in congenital heart 
disease. 
The derivation of the word stent provides a very good example of how words enter the 
language. It comes from Charles Thomas Stent, an English dentist who developed a 
material derived from the natural latex gutta-percha suitable for making dental 
impressions. This material went into commercial production under the name ‘Stents’ 
and was then used by Esser, a Dutch plastic surgeon, to stabilise skin grafts for soldiers 
who had sustained facial war wounds during the first World War. Eventually the term 
stent came to describe ‘any kind of non-biological support used to give shape or form to 
biological tissue’.
One obvious major limitation of balloon mounted stents is that they have a finite 
expanded diameter and therefore will eventually cause relative stenosis in the growing 
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child unless they can self absorb or be disrupted by further inflation, as well as this 
stents quickly become incorporated into the vessel wall and would be very difficult to 
remove surgically without destroying the vessel. Therefore care must be taken when 
implanting stents in smaller children unless there is no realistic alternative or in an 
emergency situation. 
For smaller branching vessels, where conventional angioplasty is not beneficial stent 
implantation may not affect outcome. For example in the lung periphery, the branching 
nature of the vasculature will mean that stents cross and possibly occlude side branches 
depending on the angle of incidence. In addition, the type of peripheral pulmonary 
stenosis for example that found in syndromes such as Williams (Geggel, Gauvreau and 
Lock, 2001) and Alagilles may not to respond the angioplasty with or without the 
support of stenting because of the significant thickness of the vessel wall. 
 
Stenosed pulmonary veins, either due to native disease or following repair of total 
anomalous pulmonary venous drainage, are a particular problem because of the 
tendency to recur after surgery. They can be a cause of severe pulmonary hypertension 
and failure to thrive in infants. Attempted enlargement of these veins using stent 
implantation has been disappointing because of neo-intimal proliferation 
(Balasubramanian et al., 2012). Another solution in such patients and in peripheral 
pulmonary arterial stenosis might be cutting balloon angioplasty (Barath et al., 1991) 
which has been employed to treat stenotic arteriovenous fistulae used in patients with 
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chronic renal failure for dialysis and also to treat resistant coronary stenoses. By making 
controlled tears in the vessel wall it might be possible to relieve resistant stenoses 
without using excessive force.
From the above historical perspective, it is clear that while surgeons and cardiologists 
have different approaches the benefits intended for their patients are the same. Indeed 
both groups are faced with similar potential complications. Any procedure on the heart 
or great arteries can cause unrepairable damage to these structures as well as to vital 
organs such as the brain principally by the interruption of oxygenation. Therefore a 
thorough understanding of the morphology of lesions is necessary to define potential 
risks as well as the means to minimize them. It is essential that surgeons and 
cardiologists work together to provide the best long term outcomes with the lowest 
morbidity especially when patients have complex congenital lesions with little chance 
of a ‘cure’ after a single procedure. 
Linked to the assessment of risks and benefits in applying new treatments such as those 
outlined above is the difficulty in applying evidence based practice. It is 
often not possible to compare treatment and control groups because to not offer 
treatment could be unethical if the new treatment was clearly advantageous. 
Randomised double blind controlled trials are not possible and in fact there have been 
very few randomised studies in the treatment of congenital heart disease. It could be 
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argued that some novel treatments could never have become established in the current 
regulatory environment because of the excess mortality and morbidity during the 
learning period. Therefore advances have been made incrementally by comparing 
outcomes of new treatments in terms of efficacy and complications with the natural 
history or results of previous treatments. 
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Rationale for thesis
Aims of each chapter
Chapter 1: To provide the historical background of catheter based techniques to treat 
stenoses of the heart and great vessels in children and adults with congenital heart 
disease.
Chapter 2: To determine the effects of balloon angioplasty to treat acquired baffle 
obstruction after the Mustard Procedure for Transposition of the Great Arteries. My 
contribution was to collect and analyze the data.
Chapter 3: To determine the gross anatomy, histology, efficacy and safety of cutting 
blade balloon angioplasty in an experimental animal model of pulmonary artery 
stenosis. My contribution was study design, surgical creation of the branch pulmonary 
artery stenosis (together with a Fellow in cardiothoracic surgery), cardiac 
catheterization of the animals, collection of data and analysis.
Chapter 4: To compare the results of balloon angioplasty of severe aortic stenosis in a 
cohort of infants using an antegrade catheter approach to a historical cohort in whom a 
retrograde approach was used with particular emphasis on technique. My contribution 
was study design, assisting with approximately one half of the antegrade catheter 
procedures, collection of data and analysis.
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Chapter 5: To describe the early experience of balloon mounted stent implantation in 
both native and postoperative coarctation of the aorta in older children and adults. My 
contribution was study design, assisting with 4 of the procedures, formatting of 3D CT 
reconstruction (with medical physicist colleague), collection of data and analysis. 
Chapter 6: To describe the use of balloon mounted stents in the treatment of acquired 
superior vena caval stenosis after surgical repair of partial anomalous pulmonary venous 
drainage. My contribution was to perform the procedures, design the study, follow up 
the patients and analyze the data.
Chapter 7: To bring the techniques described in chapters 2 to 6 up to date and describe 
the future direction of catheter based techniques in the treatment of native and acquired 
stenosis in congenital heart disease.
Timing of thesis
Original approval for this thesis was granted in 1993 meaning a considerable delay 
before submission. The research studies are mostly historical being performed between 
1995 and 2013 however I have endeavored to link them together and bring them up date 
them using a search of the literature. 
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Chapter 2
The management of systemic venous obstruction 
after the Mustard Procedure.
28
Introduction
Since its introduction in 1963 (Mustard et al., 1964), the Mustard procedure to redirect 
pulmonary and systemic venous return in transposition of the great arteries (Fig. 14) had 
become the preferred operation in most congenital cardiac surgical centres until the 
introduction of the arterial switch in the early 1980s. Although revolutionary in its time 
saving many lives the Mustard procedure carried a number of potential problems. These 
included failure of the systemic right ventricle, sinus node disease and atrial arrhythmias 
together with obstruction of the venous pathways. In fact obstruction to systemic or 
pulmonary venous return had become one of the major complications following the 
Mustard operation for transposition of the great arteries, with a reported incidence of 
between 13-18% (Trusler et al., 1987).
Figure 14. Diagram of the Mustard procedure for transposition of the great arteries, arrows 
indicate the superior and inferior systemic venous pathways (baffles).
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In general, re-operation was recommended for cases of pulmonary, inferior systemic or 
symptomatic superior systemic venous pathway obstruction and involved replacement 
of the baffle material with Dacron® (polyethylene terephthalate) or Goretex® (expanded 
polytetrafluoroethylene). Operative revision is often hazardous in congenital heart 
disease because of the presence of adhesions and possibly impaired myocardial 
performance and appears to be especially hazardous following the Mustard procedure 
(Trusler et al., 1987; Wells and Blackstone, 2000) possibly because of a systemic right 
ventricle. It was particularly hazardous when some form of synthetic material has 
previously been used to form the baffle. Fortunately a less invasive percutaneous 
approach to these lesions may be feasible. In 1983 Waldman described a case of 
transposition of the great arteries following Mustard atrial redirection with mid cavity 
systemic venous atrium obstruction, balloon dilatation was performed twice with initial 
success but rapid recurrence of the obstruction (Waldman, Waldman and Jones, 1983). 
In 1984, Lock reported attempted balloon dilation in 4 children with systemic atrial 
baffle obstruction (Lock et al., 1984). Three out of the 4 cases were successful and two 
were followed for 6-7 months with persistence of relief. A larger series was provided by 
the Valvuloplasty and Congenital anomalies (VACA) Registry in 1990 (Tynan et al., 
1990) with 13 out of 16 superior limb and 2 of 6 inferior limb obstructions successfully 
treated in the short term. The criteria for judging success and failure and longer term 
follow up data were not presented.
30
Venous pathway obstruction may present clinically or come to light as an unexpected 
finding during routine follow-up. It may also have implications for future endovascular 
pacing. Although lesions may be identified by precordial ultrasound, the addition of 
transoesophageal imaging provides consistent definition of the site and morphology of 
obstruction and is particularly useful when precordial ultrasound windows are restricted 
for example in older children and adolescents (Kaulitz et al., 1990).
Aims of the study 
(1) to identify the substrate causing venous pathway obstruction following the Mustard 
procedure for transposition of the great arteries using a combination of angiography 
and transoesophageal ultrasound.
(2) to attempt balloon angioplasty of lesions in which morphology appeared favourable. 
(3) when possible to follow-up the results of treatment.
Patients and methods
Patients: A search of the database revealed a total of 74 patients with transposition of 
the great arteries undergoing the Mustard procedure at the Royal Hospital for Sick 
Children Edinburgh, a total of 20 (15 male) were identified with systemic venous 
pathway obstruction on clinical grounds or on routine clinical and cardiac catheter 
follow-up. The original baffle was created from autologous or xenograft pericardium in 
all but one patient in whom Goretex® was used. Five patients presented with definite 
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clinical signs of obstruction and for the remainder the diagnosis was made at elective 
follow-up cardiac catheterization which at the time was part of routine follow-up. 
Catheterization: Cardiac catheterization was performed under general anaesthesia in all 
patients with percutaneous access via a femoral vein. The criteria for treatment of 
pathway obstruction (Fig.15) were firstly a pullback catheter gradient of ≥ 5 mmHg.
Figure 15. Angiogram of narrow superior systemic venous pathway following the Mustard 
procedure. Arrow points to site of original atrial septum.
in the absence of azygous run-off or the angiographic appearance of severe obstruction 
when azygous run-off or baffle leak was present. A decision to elect for catheter or 
surgical intervention was made on the basis of whether or not it was possible to pass a 
guide wire or if the morphology appeared favourable meaning that the obstruction was 
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relatively discrete. One child was found to have severe obstruction of both limbs 
together with very poor right ventricular function. It was felt that no treatment could be 
offered and he died shortly afterwards.  
Transoesophageal ultrasound (TOE): was performed using a dedicated Toshiba biplane 
or a prototype Odelft single plane probe connected to a Toshiba SSH140A system.  
Evaluation of the systemic and pulmonary venous pathways was made according to 
previously described techniques (Kaulitz et al., 1990). Colour flow and pulse wave 
Doppler were used to detect obstructions and any baffle leaks. In the cases which were 
treated by balloon angioplasty, examinations were repeated after intervention and 
findings correlated with the angiographic appearance.
Balloon angioplasty: was performed using a series of Meditech balloons (Boston 
Scientific, MA, USA) with expanded diameters ranging between 10 and 20 mm. The 
ratio between balloon size chosen and estimated pathway diameter was 0.7-1.3:1. 
Inflation was by hand using dilute contrast (1 part contrast to 2 parts saline) with an 
inflation/deflation cycle of 10 seconds. Inflations were performed until balloon waisting 
disappeared or up until a maximum of 6 inflation/deflation cycles with persistence of 
waisting. Pullback mean pressure gradients were made with held respiration before and 
after intervention and off-line measurement measurements of minimum and maximum
pathway diameter were made from the anteroposterior and lateral projections. The 
catheter diameter was used to correct for magnification. In 2 patients, the narrowest 
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point was only seen on transoesophageal echocardiogram because of overlapping of the 
dilated pathway on angiography in spite of the X-ray angulation employed. 
Statistical analysis 
Results are presented using medians and ranges or means with 1 standard deviation as 
appropriate and the Student t-test was used to compare groups of continuous data. 
Results 
A total of 13 children (10 male) underwent balloon dilation of systemic venous 
pathways following the Mustard procedure for transposition of the great arteries 
including one child who had previous Goretex® baffle revision. Of the patients who had 
baffle creation using pericardium, the morphology of the obstruction was discrete in 11 
patients and tubular in one. There were 4 attempted inferior baffle limb dilations and 10 
attempted superior baffle limb dilations as one patient had angioplasty to each limb on 
separate occasions. The median age at angioplasty was 4.8 years (range 1.3-12 years), 
median weight was 18.1 kg (range 9.4-36.7 kg) and median time following surgery was 
4.3 years (range 0.6-11.3 years). A total of 11 dilations in 10 patients were judged to be 
successful at the time of the procedure with loss of balloon waisting, improved 
filling of the systemic venous atrium, reduction in pressure gradients and reduction in 
azygous and/or hemi-azygous run-off in those with SVC obstruction. Where small 
baffle leaks were identified (n=3) there appeared to be subjectively less shunting on 
colour-flow mapping than before the procedure.
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Balloon dilation reduced the mean pull back pressure gradient (Fig. 16) across 
obstructions from a mean of 10.3 mmHg (SD 5.4, range 4-20) to mean of 4 mm Hg (SD 
1.8, range 0-8, p=0.0001). The minimum diameter of the pathway (Fig. 3) averaged 
over 2 orthogonal planes increased from a mean of 5.1 mm (SD 1.6, range 3-8) to mean 
of 10 mm (SD 3.3, range 4.7-14.4, p<0.0001). The only complication encountered was a 
localised dissection identified by TOE alone during an otherwise successful procedure. 
A further study one month later showed that the neo-intimal flap had adhered to the 
baffle wall. Of the 10 successful procedures, 5 were followed-up with repeat cardiac 
catheterisation and TOE at a median interval of 1.6 years (range 1-3.2 years) with 
persistence of benefit. 
Surgery: A total of 9 patients had surgery including 3 patients who had unsuccessful 
balloon dilation procedures. In one case with severe superior limb obstruction, the left 
superior vena cava was anastomosed to the left atrial appendage at the time of surgery. 
In a further patient with severe obstruction of both limbs a bidirectional cavopulmonary 
connection was performed and in the remaining patients the atrial baffle was 
refashioned with Goretex®. Three patients died, 2 could not be separated form 
cardiopulmonary bypass and the one who had bidirectional cavo-pulmonary connection 
died of multi-organ failure after 10 days.
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Figure 16. Pullback pressure gradients (above) and minimum pathway diameters (below) 
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Discussion
The incidence of baffle obstruction in this patient population was moderately high at 
27% when compared to the literature (Trusler et al., 1987). Most obstructions were 
morphologically discrete and occurred at the site of the remnant of the atrial septum. 
Sub-total resection of the atrial septum during initial surgery might result from trying to 
avoid the incision extending into the inter-atrial groove and the artery to the sinus node 
superiorly or towards the atrioventricular node inferiorly. Obstructions presenting early 
after surgery tend to be of this type while those presenting later after surgery often have 
a tubular shape possibly due to shrinkage of pericardial baffle material. In some cases 
the mechanism of obstruction is a combination of both remnant of the atrial septum and 
baffle shrinkage. Most patents in the above series had baffles made of pericardium. 
Previous studies have suggested that baffle obstruction is more likely after the use of 
synthetic material which makes the prospect of surgical revision even less attractive.  
In our series, ballon angioplasty appeared to be successful in around 75% of selected 
patients in the short term with a low incidence of side effects. The mechanism of relief 
is unclear but probably involves some splitting of remnant of the atrial septum. 
Therefore, balloon angioplasty would not effective for obstruction caused by redundant 
folds of synthetic material, calcified pericardium or lesions with a tubular morphology. 
In this series there was only one minor complication which was a neo-intimal flap 
which was only seen on trans-oesophageal echocardiogram. 
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As this is only an observational study, it is not possible to compare surgical revision to 
balloon angioplasty as the cases initially selected for surgery were ones in whom the the 
morphology was unsuitable for angioplasty and were often not contemporaneous. 
However this small series does highlight the risks of surgical re-intervention post 
Mustard procedure. In retrospect, the balloon sizes in 2 early unsuccessful attempts at 
10 and 12 mm were probably inadequate and should have been larger. For obstructions 
with a tubular shape stent implantation either using balloon expanded or self expanding 
stents offers a useful alternative (BuLock et al., 1998).
Conclusion
Balloon angioplasty alone may have a place in the percutaneous treatment of some 
cases of Mustard baffle obstruction with a discrete morphology. It is possibly safer than 
surgical re-intervention in this population.
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Study Limitations
1. This is a retrospective observational study offering no direct comparison with 
surgical treatment as no angioplasty attempt was made in patients when the stenosis  
was not judged to be favourable.
2. There was no differentiation between patients treated with clinical evidence of baffle 
obstruction and those whose baffle obstruction was found on routine catheter follow-
up. In asymptomatic cases with superior limb obstruction and azygous run-off the 
need for intervention is questionable on clinical grounds.
3. It may be that subclinical baffle obstruction may have a place in limiting exercise 
tolerance in these patients and therefore intervention could be warranted however this 
was not tested. 
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Chapter 3
Experimental branch pulmonary artery stenosis 
angioplasty using a novel cutting balloon.
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Introduction
Following experimental work in the early 1980s (Lock et al., 1981), balloon angioplasty  
of hypoplastic and/or stenotic branch pulmonary arteries has become an established 
practice in children (Lock et al.,1983; Rothman et al., 1990; Kan et al., 1990). However 
acute anatomical success of pulmonary artery angioplasty is seen in only 50% to 60% of 
patients, with a 16% restenosis rate at late follow-up (Rothman et al., 1990; Kan et al., 
1990; Hosking et al., 1992). The natural elastic recoil of the vessel or a non distensible 
scar from previous surgical treatment may contribute to these results. Isolated 
congenital pulmonary artery branch stenosis occurring, for example, in Williams, 
Noonan or Alagille syndromes, can also be particularly difficult to dilate successfully 
(Beekman, Rocchini and Rosenthal, 1989; Ring el al., 1985; Gentles, Lock and Perry, 
1993) because of the increased thickness of the tunica media. High pressure balloons 
(Gentles, Lock and Perry, 1993) and more recently endovascular stenting have been 
employed with impressive acute and intermediate term success (O’Laughlin et al., 1993; 
Fogelman et al., 1995). However this latter treatment is less applicable in the younger 
child as it’s use is limited by stent maximal expandable diameter, the disadvantages of a 
foreign body and the requirements of long term management (Ing et al., 1995). In 
addition peripheral stenoses especially at branching points are less attractive lesions for 
stent implantation (Fogelman et al., 1995).
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As an alternative to addressing resistant stenotic lesions with conventional balloons, a 
bladed balloon angioplasty catheter has been developed originally for resistant coronary  
stenoses (Barath et al., 1991). These bladed or cutting balloons have four longitudinally 
mounted blades with a cutting depth of 0.15 mm mounted at 900. Tough intimal 
atheromatous plaques can be incised, allowing dilation with less chance of vessel 
rupture (Unterberg et al., 1993). This current study was undertaken to determine the 
gross anatomy, histology and efficacy of balloon angioplasty using a cutting blade 
balloon angioplasty catheter in the setting of experimental pulmonary artery stenosis 
using an animal model.
Animals and Methods
Surgical creation of branch pulmonary artery stenosis was undertaken in nine two-week 
old pigs, each weighing approximately 5kg. The animals were premeditated with 
akmezine 0.25 ml/kg (97.9% ketamine, 2% acepromazine and 0.11% atropine) and 
general anaesthesia was maintained by a mixture of halothane, nitrous oxide and 
oxygen. A left lateral thoracotomy was performed in the fifth intercostal space, and an 
intercostal nerve block was induced with 4 ml of 0.5% bupivicaine diluted 1:1 with 
saline. The left lung was collapsed and the left pulmonary artery was identified by blunt 
dissection. In seven cases it was necessary to divide and ligate a left superior vena cava 
to provide access to the left pulmonary artery. A single 2-0 chromic catgut suture 
(Ethicon, Johnston and Johnston) was placed around the artery and three 6-0 prolene 
sutures (Ethicon, Johnston and Johnston) were placed circumferentially around the 
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vessel as previously described (Lock et al., 1981). Each prolene suture was passed 
through the adventitia and the media of the vessel twice and tied. The catgut suture was 
ligated over an angled forceps twice to reduce the vessel diameter by approximately 
50%. An additional bupivicaine intercostal block was administered and the lung re-
expanded. The chest was closed in layers with 2-0 Dexon (Ethicon, Johnston and 
Johnston), any remaining air in the left chest was evacuated via a chest drain placed 
through the wound and the skin was closed with 4-0 Dexon.
Antibiotic prophylaxis was provided with a single intramuscular dose of long acting 
benzylpenicillen 150,000 U for animals weighing less than 20kg and 300,000 U for 
those weighing more than 20kg. Postoperative pain relief was provided by the nerve 
block augmented by intramuscular buphenorphine (0.01 mg/kg). While all the animals 
survived surgery one died two weeks postoperatively. This animal, the smallest in the 
series had evidence of mediastinal lymphadenopathy and pleural adhesions at autopsy 
with infection being the presumed cause of death. 
Balloon angioplasty. Cardiac catheterization was performed under general anaesthesia 
41± 10 days after the surgical creation of branch pulmonary artery stenosis. The right 
femoral vein was entered percutaneously and a 7 French venous sheath together with a 
back bleed tap and sidearm was placed into the vein. A 5 French right coronary artery 
catheter (Judkins type, Cordis Inc, Florida) was advanced into the heart and pressures in 
the right atrium, right ventricle and left pulmonary artery proximal and distal to the area 
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of stenosis were recorded by fluid-filled pressure manometers zeroed at mid-atrial level. 
The right coronary artery catheter was replaced with a 7 French Gensini catheter and a 
selective angiogram was performed in the left pulmonary artery by hand injection 
(Isovue 300, Squibb Inc). Angiograms were recorded in the postero-anterior projection 
onto both videotape and hard copy. The diameters of the pulmonary artery at the level of 
stenoses were measured offline by using the known catheter diameter to correct for 
magnification.
Angioplasty of pulmonary artery stenoses was attempted in the eight surviving animals. 
One animal was found to have complete obstruction of the left pulmonary artery which 
could not be crossed with a guide wire and this was confirmed at autopsy. Of the 
remaining seven animals, five had angioplasty with a 6 mm diameter x 15 mm long 
cutting balloon (Interventional Technologies Inc, California, Fig. 17). 
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Figure 17. Diagram of Interventional Technologies cutting balloon. White arrows show radio-
opaque markers, black arrows denote cutting atherotomes.
Because the supply of cutting balloons was limited and re-use was not always possible, 
two animals underwent balloon angioplasty in the standard fashion using catheter-
mounted balloons (Cordis Inc.). Cutting balloons were introduced over a 0.014 “ guide 
wire for stability and through an 8 French long transseptal sheath (USCI Angiographic, 
Massachusetts) to protect both balloon and cardiac structures. The sheath with 
intraluminary balloon was positioned across the area of stenosis within the left 
pulmonary artery. The sheath was withdrawn to expose the balloon and a small amount 
of contrast was injected into the sheath (through the sidearm) to monitor position. After 
de-airing, the balloon was inflated with a singe inflation of dilute contrast. The balloon 
was deflated, carefully withdrawn into the sheath and removed. The lesion was 
recrossed with a 0.035” hydrophilic wire (Terumo Corp, Tokyo, Japan) and the 7 French 
Gensini catheter was advanced over the wire to the distal left pulmonary artery. 
45
Pullback pressure gradients (Fig. 18 A and B) were repeated, as well as selective 
angiography with remeasuring of the diameters of the dilated segments.  
A
B
Figure 18. Pullback pressure tracing across the left pulmonary artery in animal 1 before (A) and 
after (B) cutting balloon angioplasty, arrow points to site of stenosis.
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For standard balloon angioplasty, 2 cm long balloons were selected with a diameter 
approximately three times the diameter of the stenosis but not greater than two times the 
diameter of the normal pulmonary artery. One animal had standard balloon angioplasty 
following predilation with a cutting balloon. Both this animal and the one treated with a 
cutting balloon were killed immediately with a euthanasia solution (Euthanyl, MTC 
Pharmaceuticals). These animals had also undergone cutting balloon angioplasty in 
smaller branches to observe the effect on normal vessels. The distal branches chosen 
had a diameter of approximately 3 to 4 mm (i.e., less than the cutting balloon’s 
expanded diameter).
Follow-up. Surviving animals had follow-up cardiac catheterizations after 42 ± 3 days. 
Percutaneous entry was from the femoral vein and pressures in the right heart, and 
proximal and distal pulmonary arteries were measured. Selective angiography was 
performed in the left pulmonary artery as before. Following catheterization, all animals 
were killed using euthanasia solution.   
 
Pathological examination. The two animals killed immediately were prepared for 
electron microscopy. Immediately after death a window in the chest wall was 
created, and the aorta, superior vena cava and inferior vena cava were ligated. The main 
pulmonary artery and aorta were cannulated and the heart-lung 
preparation was perfused with saline followed by 2L of fixative containing 2% 
glutaraldehyde before removal of the left pulmonary artery (to prevent smooth 
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muscle contraction artefact). The pressure generated in the perfusion preparation was 
kept below 50 mmHg. The cut luminal surface of the artery was used for scanning 
electron microscopy.
For the remaining animals, the left pulmonary artery was dissected out and placed in 
10% buffered formalin. The specimen of pulmonary artery was cut lengthways and the 
appearance of the luminal and adventitial surface was examined. Serial circumferential 
histological sections were cut from paraffin-embedded tissue, stained with hematoxylin 
and eosin, and examined by light microscopy.
Ethical approval was granted by the Animal Services Committee of the Hospital for 
Sick Children. Data are expressed as median with ranges or as mean ± 1 SD.
Results
The schedule of interventions and outcomes for each animal is given in Table 1. The 
median weight at angioplasty was 24 kg (range 14-39.2). In all animals, the mean peak 
systolic pressure gradient across the left pulmonary artery fell from 8.3 ± 2.3 mmHg to 
3.2 ± 3.1 mmHg, and the mean diameter of stenoses increased from 4.5 ± 2 mm to 5.6 ± 
2 mm at initial angioplasty. There was no change in peak right ventricular pressure 
before (25 ± 3 mmHg) or after (23 ± 5 mmHg) dilation. The only acute complication 





































































































































































































































































































withdrawn into the sheath and attempts to exteriorize led to the remnant being torn from 
the catheter shaft and left in the femoral vein. This animal had been scheduled to be 
killed immediately. One other animal died two weeks post angioplasty, after a regular 
balloon dilation had produced a poor result. At autopsy, there was blood in the 
pericardial sac; however the site of vessel perforation could not be identified. There 
were no rhythm disturbances during angioplasty.
Of the five animals treated with a cutting balloon, all showed a modest increase in 
vessel diameter although the measured pre-dilation diameters in two animals were 
greater than 6 mm. One of these animals underwent angioplasty with a regular balloon 
which produced no further increase in vessel diameter and both animals were killed 
immediately and prepared for electro microscopy. Naked eye examination revealed cuts 
in the luminal surface presumably because the blades added to the overall diameter (Fig. 
17). 
Scanning electron microscopy showed linear tears at the site of the angioplasty 
extending through the intima into the media (Fig. 19). These two animals also
underwent cutting balloon angioplasties of normal distal vessels which produced no 
gross pathological or histological evidence of damage.
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Figure 19. Scanning electron micrograph with 1 mm distance marker showing luminal surface 
of pulmonary artery. Key: white arrow points to stenotic ridge and black arrow to linear tear from 
cutting balloon. 
The three surviving animals in which the cutting balloon had been employed continued 
to demonstrate growth of the stenotic area at follow-up, although in one animal this 
further increase was minimal. At follow-up, this latter animal underwent repeat 
angioplasty with a regular balloon with an increase in diameter of only 4.1 mm to 5.3 
mm. The single survivor after regular angioplasty showed some evidence of restenosis 
at follow-up. No pulmonary artery aneurysms were seen at recatheterization in any of 
these four surviving animals. All were killed and underwent pathological and 
51
histological examination, which showed healing of the cut luminal surface and no 
evidence of adventitial haemorrhage.
Discussion
This preliminary study shows that ‘cutting’ balloons may be employed through a long 
sheath for angioplasty of branch pulmonary artery stenoses without complications 
(haemorrhage or aneurysm formation). The mechanism of angioplasty appears to be 
creation of regular incisions of the intima and media, which may allow for a more 
controlled widening of the vessel than the tearing seen after standard balloon 
angioplasty (Edwards et al., 1985). These incisions were also shown to be healed 
completely by four to six weeks. One technical limitation of this study was that in 
several cases the diameter of stenoses was similar to the available balloon diameter and 
angioplasty by the cutting balloon produced only a modest acute increase in vessel 
diameter. In two of the three surviving animals however a further increase in vessel 
diameter at follow-up was seen, not unlike that noted after conventional angioplasty. 
Abrasions or cuts in the luminal surface of normal distal vessels in which the cutting 
balloon was deployed were not seen because these vessels were easily distensible.
One serious technical problem was rupture of a cutting balloon that could not be 
withdrawn into the sheath and eventually tore away from the catheter shaft. 
Reuse of this balloon may have caused this complication. Because only two animals had 
angioplasty with regular balloons, comparison with cutting balloons was impossible; 
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however short term follow-up angiograms suggested that pulmonary artery stenotic 
areas treated with cutting balloons continued to grow.
Available cutting balloons are designed for use only in coronary angioplasty and as such 
have a maximum expanded balloon diameter of 6 mm but only track a coronary 0.014” 
guidewire. To further explore clinical applications, such as angioplasty of branch 
pulmonary artery stenoses or creation of atrial septal defects, redesign would be 
necessary to make balloon and catheter more robust. This might include increasing 
catheter size and allowing tracking over a stronger guidewire (such as 0.035”). 
Additionally, a larger catheter would be less likely to tear following balloon rupture.
Conclusion
In a case of branch pulmonary artery stenoses, where stenting or surgery are not 
justified, dilation with a cutting balloon may allow controlled tearing. It may be 
additionally useful in isolated or multiple congenital congenital branch pulmonary 
stenoses which tend to respond less well to regular angioplasty. In cases where the 
stenotic diameter is not much greater than the available cutting balloon expanded 
diameter, the cutting balloon can can be used to produce linear tears in the artery that 
can be further stretched (or torn) by standard angioplasty techniques.
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Chapter 4
Balloon dilation of severe aortic stenosis in the 




Aortic stenosis is relatively uncommon and occurs in only 3-5% of all patients with 
congenital heart disease (Keith, Rowe and Vlad, 1967). Of these only around 10% will 
require treatment in the neonatal period either because the systemic circulation is duct 
dependent or because of heart failure (Sandor et al., 1980). The term ‘critical’ should 
only be applied when the stenosis is so severe that continued patency of the arterial duct  
is required to maintain life. 
Balloon dilation of the aortic valve was first described by Lababidi (1984) and has since 
been applied successfully to infants and children as a alternative to surgical valvotomy 
(Vogel et al., 1989; McCrindle, 1996). In recent years, the technique has been used in 
neonates with severe or critical aortic valve stenosis with results comparable to surgical 
approaches (Zeevi et al., 1989) although in many centres surgery remains the preferred 
option. During the procedure, the left heart has generally been approached in a 
retrograde fashion through the femoral (Zeevi et al., 1989), umbilical (Beekman, 
Rocchini and Andes, 1991), or right common carotid arteries (Fischer et al., 1990; Donti 
et al., 1995). Femoral artery access in neonates carries the risk of damage to the vessel 
resulting in thrombosis and potential limb complications (Vogel et al., 1989; Burrows et 
al., 1990). Additionally, it is often necessary to exchange or withdraw catheters 
increasing the possibility of damage to the arterial wall.
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An anterograde approach through the heart from the femoral vein would eliminate the 
risk of arterial compromise and would be superior to the retrograde approach, provided 
that the procedure was as effective as retrograde access, could be performed quickly and 
was free from neurologic complications due to wire manipulation. Additional benefits 
of this approach could result from the wire reliably crossing the hemodynamic orifice of 
the valve rather that potentially piercing a valve leaflet, leading to severe aortic 
incompetence on dilation. Also performing the procedure in the direction of blood flow 
might reduce the tendency of the balloon to ‘bounce’ in and out of the valve as blood is 
ejected from the heart. To this end, encouraging experience with an anterograde 
approach was reported (Hausdorf et al., 1993) in a group of nine children ranging in age 
from 1 day to 11 years. Reported here is our experience with an anterograde approach to 
aortic valve balloon dilation in a consecutive group of 11 neonates with severe aortic 
valve stenosis, with particular emphasis on the technique and comparison of results to a 
similarly matched group undergoing dilation in a retrograde fashion from the aorta.
Methods
Echocardiographic and clinical assessment: All patients underwent a complete two-
dimensional echocardiographic study before intervention, including assessment of the 
ventricular morphology and the diameter (at the hinge points) of the mitral and aortic 
valves. In cases where the left ventricle did not reach the apex of the heart, a Rhodes 
score was measured (Rhodes et al., 1991). Left ventricular ejection was measured using
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 a biplane Simpson method. Severe aortic stenosis was defined as an arterial duct-
dependent systemic circulation, symptomatic heart failure or a derived peak to peak 
Doppler gradient > 60 mmHg (Beekman et al., 1992).
Degree of aortic valve incompetence was measured semiquantitatively, using the ratio 
of regurgitant jet width to annulus size (Nishimura et al., 1992). Mitral valve 
incompetence was assessed qualitatively by Doppler colourflow mapping and 
categorized as nil, trivial, mild, moderate or severe. In two of the earlier group 2 
patients, Doppler colour flow mapping of the mitral valve was not available. Unless 
otherwise stated, pressure gradients are those measured at cardiac catheterization. 
Echocardiography was repeated within 24 hours of the procedure to assess ventricular 
function and the degree of aortic and mitral valve incompetence.
Patients. Group 1: Between November 1994 and November 1995, 11 consecutive 
neonates with severe aortic valve stenosis underwent attempted balloon dilation of the 
aortic valve using an anterograde catheter approach. There were nine male and 2 female 
neonates, and all but one was < 28 days old (median age 6 days, range 1-42; median 
weight 3.5 kg, range 2.2-4.25). Four patients presented with congestive heart failure on 
day 1 of life; four had a murmur and congestive heart failure within the first week of 
life; and two had a murmur and congestive heart failure and presented at 2 weeks of life. 
The remaining patient, who presented with a murmur on day 1, remained well but 
developed an increasing aortic valve echocardiographic-Doppler gradient.
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Six patients had a patent arterial duct: shunting was predominantly right to left in two 
and bidirectional in four. One patient had partial anomalous pulmonary venous drainage 
of the left upper pulmonary vein to the innominate vein, and two had mild hypoplasia of 
the aortic isthmus. Five patients had reduced left ventricular function (ejection fraction 
between 10% and 40%), and in four of these five patients, the mitral valve chordae and 
papillary muscle apparatus had a bright appearance on the echocardiogram, suggesting 
endocardial fibrosis. Three patients had hypoplasia of the left ventricle with a Rhodes 
score of -0.14, +0.3 and +1.4 respectively; in another two patients, the left ventricle was 
dilated (end-diastolic dimension 2.2 and 2.3 cm, respectively, both above the 95th 
percentile for age).
Group 2: Between April 1985 and April 1995, 15 patients underwent attempted balloon 
dilation of the aortic valve from a retrograde catheter approach, including two who had 
an unsuccessful attempt using an anterograde approach (median 3 days, range 1 to 35; 
median weight 3.5 kg, range 2.5 to 4.4). Five patients presented with heart failure and 
poor perfusion on day one of life, three with heart failure within the first week and one 
each at 10 days, 14 days and 1 month. Three patients were found to have a murmur 
within the first few days of life and the diagnosis was made by echocardiogram at 1, 6 
and 20 days of age. One patient was diagnosed by fetal echocardiography and 
transferred to the catheter laboratory on day one of life while receiving a prostaglandin 
infusion. Of the six patients with evidence of right to left shunting across a patent 
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arterial duct, bidirectional shunting was present in one and two had coarctation of the 
aorta. Three patients had a hypoplastic left ventricle (end-diastolic dimensions 0.7, 1.5 
and 1.55 cm, respectively, all below the fifth percentile for age), and one had a dilated 
ventricle (end-diastolic dimension 2.53 cm). In six patients, an echo-bright appearance 
of the mitral valve chordae and papillary muscle apparatus suggested endocardial 
fibrosis. One patient had surgical open valvotomy on day 1 but required further 
intervention at 9 days of age.
Procedures. All procedures were performed under general anaesthesia with 
mechanical ventilation.
Group 1: In the first patient, percutaneous entry was achieved from the right femoral 
vein and umbilical artery. After unsuccessful attempts to cross the valve retrogradely 
from the ascending aorta, a 4F right coronary catheter (Judkins type, Cook) with a 2.5 
curve was advanced from the femoral vein and passed through the oval foramen and 
into the left ventricle. Counterclockwise rotation allowed the tip to turn towards the left 
ventricular outflow tract. A guide wire was passed across the aortic valve into the 
ascending aorta and snared (Amplatz, Cook) from the retrograde umbilical arterial 
catheter to stabilize its position. In the remaining 10 cases, stable wire position was 
achieved from the femoral vein via an antegrade approach with no attempted retrograde 
approach. A 4F right coronary catheter (2.5 curve) was used to enter the left ventricle 
through the foramen ovale in three cases, a 5F right coronary catheter (2.5 curve) in five 
cases and a 5F end-hole balloon catheter (Critikon, Inc., Ontario) in one case. In one 
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patient, percutaneous entry into the femoral artery was performed for pressure 
monitoring. Pressures in the left ventricle and aorta were measured and the aortic valve 
annulus diameter was measured from a left ventricular angiogram (n=7) or ascending 
aortogram (n=2) using the catheter diameter to correct for magnification. The initial 
guide wires used to cross the valve included a 0.014-in. coronary wire (C.R. Bard Inc.) 
(n=1), a 0.035-in. flexible tipped wire (Wholey, Mallinckrodt Medical) (n=5), a 0.035- 
or 0.018-in. hydrophilic wire (Terumo Corp., Tokyo, Japan) (n=2) or a 0.025-in. Teflon-
coated wire (Cook Inc.) (n=1). If possible, the wire was directed into the descending 
aorta; however, in four patents, the soft tip of the guide wire was left in the innominate 
artery for stability. The coronary catheter was curled in the left ventricle and then 
advanced over the wire to either the ascending or descending aorta, and the initial wire 
exchanged for a 0.035-in. guide wire (Cook Inc.) (Fig. 20, left). A 2-cm long balloon 
(Cordis Corp.) with a diameter 90% to 100% of the estimated aortic annulus diameter 
was selected and advanced over the guide wire. Care was taken to position the balloon 
within the left ventricle clear of the mitral valve apparatus. After an inflation with ⅓ 
dilute contrast medium (Fig. 20, right), the balloon was withdrawn and replaced with 
the right coronary catheter. 
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Figure 20. Left, Guide wire looped in the left ventricular apex, clear of the mitral valve 
apparatus, crossing the aortic valve and positioned in the descending aorta of a 3.8-kg neonate. 
Right, Balloon dilation of the aortic valve using a 6-mm × 2-cm balloon over a 0.035-in. wire, 
stabilized in the descending aorta. Inflation produced a decrease in peak systolic gradient from 
100 to 26 mm Hg, with no residual aortic or mitral valve incompetence.
Pressures in the left ventricle and aorta were remeasured, and the procedure was 
repeated if no change in gradient was documented. In four patients, the balloon size was 
increased by 1 mm and in one patient by 2 mm. Ventriculography was performed before 
and after the dilation to assess valve mobility, chamber function and mitral 
regurgitation. 
Group 2: Retrograde balloon dilation was from an umbilical artery approach in one 
patient and through the femoral artery in the remaining 14 patients. The aortic valve 
annulus diameter was estimated from the ascending aortogram, and the valve was 
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dilated using the appropriate balloon diameter (see Procedures, Group 1) introduced 
over a guide wire whose tip was curled in the left ventricular apex. In two patients, the 
balloon size was increased by 2 mm. Aortography was repeated to assess aortic valve 
mobility and degree of aortic regurgitation.
Statistics 
Normally distributed continuous variables are presented as mean value ± 1 SD and other 
variables as medians with ranges or frequencies. Between-group comparisons were 
made with a Student t test, chi-square with Fisher exact test on Mann-Whitney U test, 
depending on whether data was parametric or nonparametric. A p value < 0.05 was 
considered significant.  
 
Results
Group 1: Of the 11 attempted anterograde dilations, the aortic valve was successfully 
crossed in all but 2 patients. In the first of these, the balloon was successfully advanced 
across the valve but was poorly seated, and the dilation was ineffective; in the second, 
an anterograde approach was abandoned after the development of atrial flutter requiring 
overdrive pacing for termination. These two patients subsequently underwent retrograde 
dilation at the same catheterization and are included in group 2. Clinical and 
haemodynamic data for the remaining 9 group 1 patients are presented in Table 2. 
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LVEF (%) Peak systolic gradient 
(mmHg)





1/2 3.1 10 22 6 6 50 18
2/6 3.9 16 25 6 7 39 23
3/6 3.5 72 86 8 8 113 19
4/16 3.3 40 48 5 5 60 10
5/42 4.3 72 76 6 6 46 14
6/2 3.8 NA NA 7 6 100 26
7/1 3.2 10 28 6 6 20 4
8/2 3.5 64 75 7 8 80 24
9/6 2.2 80 80 5 5 53 17
Table 2. Group 1 (antegrade approach to aortic valve): Clinical and Haemodynamic Data
LVEF = left ventricular ejection fraction; NA = not available; Pre = before the procedure; Post = 
after the procedure; Pt = patient; Wt = weight.
The median balloon diameter was 6 mm (range 5 to 8), the mean ratio of balloon 
diameter to aortic annulus diameter was 1 ± 0.0. The median fluoroscopy time was 40 
min (range 22 to 63). Although ventricular ectopic activity was not uncommon no 
additional  prolonged or haemodynamically compromising rhythm disturbances 
occurred during wire catheter or balloon manipulation. The initial and post-procedural 
peak to peak systolic gradients across the aortic valve were 62 ± 20 and 17 ± 5 mmHg, 
respectively (P=0.001). 
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Left ventricular ejection fraction, as estimated by echocardiography, changed from a 
mean of 45 ± 21% (range 10% to 80%) to a mean of 55 ± 19% (range 22% to 86%) 
within 24 h of the procedure (p = 0.002). Of the four patients presenting with poor left 
ventricular performance, three had normal function by 4 months and one continued to 
have poor ventricular function. This latter child developed a calculated peak to peak 
gradient of Doppler of 81 mmHg and had an uneventful surgical valvotomy at 4 months 
of age. One other patient with normalized left ventricular function has a Doppler peak to 
peak gradient of 56 mmHg at 6 months after the procedure and was scheduled for re-
intervention. 
Complications: Echocardiographically, of the 7 patients with no preceding aortic 
incompetence, 4 developed mild aortic insufficiency with the remaining 3 having none 
after the procedure. One patient with mild aortic incompetence before dilation had 
moderate incompetence after the procedure, and in one further patient the degree of 
regurgitation went from trivial to moderate. The ratio of regurgitant jet width to aortic 
annulus diameter increased from a mean of 0.03 to a mean of 0.16 (p = 0.008). From 
qualitative assessment  using Doppler color flow mapping, the degree of mitral valve 
incompetence was unchanged in four patients, whereas in one it appeared to decrease 
from moderate to mild. In four patients the degree of mitral valve incompetence 
increased: two developed mild and two moderate mitral regurgitation. In the latter two 
patients, the mitral regurgitation jet appeared to arise from the anterior mitral leaflet and 
may have represented damage from the wire or balloon catheter. One patient was treated 
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with afterload reduction and diuretic drugs, and in both patients the degree of mitral 
regurgitation decreased to mild within 1 week.
 
All femoral pulses were normal after catheterization, except in the one patient (11%) in 
whom a catheter had been placed in the femoral artery for pressure monitoring. Gradual 
resolution of the compromised pulse in this patient occurred after thrombolytic therapy. 
The smallest patient (2.2 kg) had echocardographic evidence of a 1 cm x 0.4 cm 
thrombus within the left atrial appendage after the procedure and this was treated 
uneventfully with low molecular weight heparin. There were no acute deaths or 
neurological sequelae.
Group 2: The valve could not be crossed in the first 2 patients, leaving 13 who 
underwent dilation. Clinical and haemodynamic data for group 2 
patients are presented in Table 3. 
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1/5 4.4 NA NA 8 8 124 36
2/1 3.2 NA NA 6 6 5 0
3/11 3.5 NA NA 5 5 19 0
4/2 2.7 NA NA 6 4/5/6 20 14
5/9 3.5 NA 67 7 7 63 20
6/3 3.5 78 78 6 6 50 20
7/25 3.0 79 85 8.8 8 54 14
8/1 3.8 10 32 6 6/8 49 7
9/3 3.5 67 56 8 8 95 17
10/35 3.3 36 42 7 7 61 26
11/7 3.5 69 84 6.5 7 45 16
12/1 2.9 54 NA 7.4 7 38 6
13/17 3.5 28 47 7 6 50 24
Table 3. Group 2 (retrograde approach to aortic valve): Clinical and Haemodynamic Data 
Abbreviations as in Table 2.
The mean ratio of balloon diameter to aortic annulus diameter was 1 ± 0.06, and the 
median fluoroscopy time was 18 min (range 5 to 72). Fluoroscopy times are skewed by 
one of the unsuccessful anterograde dilation attempts. The initial and post-procedural 
peak to peak systolic gradients across the aortic valve were 52 ± 17 mmHg and 17 ± 5 
mmHg respectively (p = 0.001). Measured left ventricular ejection fractions went from 
53 ± 18% (range 10% to 79%) to 58 ± 12% (range 32% to 85%, p = 0.1).
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Complications: There were six deaths after retrograde balloon dilation (mortality rate 
46%).  All deaths were related to the occurrence of severe (n = 5) or moderately severe 
(n = 1) aortic incompetence. Two patients underwent an emergency Ross procedure and 
one patient a Konno procedure 5 weeks after dilation. In the latter patient, complete 
detachment of an aortic valve leaflet was noted at operation. The degree of aortic 
incompetence was unchanged in four patients (nil in two, mild in two). In the remaining 
nine patients, all of whom had no incompetence before dilation, regurgitation increased 
and became severe in five and moderate in four. The ratio of regurgitant jet width to 
aortic annulus diameter increased from a mean of 0.02 to a mean of 0.51 (p = 0.003). Of 
the 11 patients in whom a qualitative assessment of mitral incompetence is available, 1 
demonstrated a decrease from moderate to mild and 1 in whom anterograde dilation was 
attempted developed mild regurgitation after the procedure. In the remaining nine 
patients, the degree of mitral regurgitation was unchanged. Of the eight patients who 
developed femoral artery thromboses (62%), one also had laceration of the femoral 
artery that required surgical repair. In one patient, the pulse resolved with heparin 
therapy alone, and five underwent successful thrombolysis leaving two lesions 
unresolved. Other complications included ventricular fibrillation during balloon 
inflation in one patient, which also produced a small tear in the ascending aorta and an 
episode of bacterial endocarditis in another patient. There were no acute neurological 
events among survivors.
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Comparison of groups 1 and 2 (Table 4): There were no significant differences between 
the two groups in age or weight at dilation, peak systolic pressure gradient before 
dilation, left ventricular ejection fraction or ratio of maximal diameter before and after 
the procedure. Although the anterograde approach took significantly longer, the 
retrograde approach was associated with significantly higher mortality, an increased 
incidence of arterial complications and more severe aortic regurgitation. There was no 
significant difference in degree of mitral regurgitation between the 2 groups after the 
procedure.  
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Group 1 (n = 9) Group 2 (n = 13) p value
Age (days)
  Median 6 3 0.5
  Range 1-42 1-35
Wt (kg)
    Median 3.5 3.5 0.5
    Range 2.2-4.25 2.5-4.4
Before dilation
    Peak gradient (mmHg) 62 ± 20 52 ± 17 0.44
    LVEF (%) 45 ± 21 53 ± 18 0.5
    AI ratio
        Median 0 0 0.5
        Range 0-0.13 0-0.12
Balloon/annulus ratio 1 ± 0.06 1 ± 0.06 0.64
Fluoroscopy (min) 43 ± 9 25 ± 10 0.03*
After dilation
    Peak gradient (mmHg) 17 ± 5 17 ± 5.5 0.9
    LVEF (%) 55 ± 19 58 ± 12 0.8
    AI ratio 0.16 ± 0.08 0.51 ± 0.24 0.03*
Increase in MR 2.2-4.25 0 0.17
Arterial thrombosis 11% 62% 0.03*
Mortality rate 0% 46% 0.046*
Table 4. Comparison of Anterograde and Retrograde approaches to Aortic Valve Dilation. 
AI=Aortic regurgitation jet width/annulus ratio. Increase in MR number of patients who went 
from mild or less to moderate or more. 
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Discussion
Mortality: The present series compares retrograde and anterograde catheter approaches 
for dilation of severe aortic valve stenosis in neonates. Not all patients had arterial duct 
dependent systemic circulations: thus the term ‘severe’ is used in preference to ‘critical’. 
Because the present trial was not a randomized, controlled one, the two groups are not 
strictly comparable, and several of the retrograde dilation attempts were performed 
early in the evolving experience of catheter-directed therapies. In addition, three earlier 
patients had qualitatively small ventricles, predating attempts to assess candidacy for 
biventricular repair and may not have been suitable retrospectively for dilation but 
instead should have been treated with single ventricle palliation. Because these three 
patients predated formal echocardiographic application of the Rhodes scoring system 
(Rhodes et al., 1991), we were unable to retrospectively assign a reliable score and must 
accept this limitation of the retrospective control. Mortality rates from other series of 
retrograde balloon dilation of the aortic valve range from 10% to 20% (Zeevi et al., 
1989; Beekman, Rocchini and Andes, 1991; Fischer et al., 1990). In our experience, if 
patients who underwent angioplasty before 1990 are excluded (which includes those 
with unequivocally small ventricles), the mortality rate for the retrograde group falls to 
33% which is still significantly greater than the mortality for the antegrade group. In 
addition, the incidence of predominantly right to left shunting at the ductal level was 
higher in the retrograde group. Although the high mortality for the retrograde group 
may be peculiar to the operators or technically related as described later, the mortality is 
within the confidence limits of the published data, and all procedures were undertaken 
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by one of two primary operators, whether anterograde or retrograde. Nevertheless, the 
differences in mortality for the two approaches are striking and several of the patients 
who died after an attempted retrograde approach had normal ventricular size and 
function.   
Aortic incompetence. We believe that the major factor leading to a poor outcome after 
retrograde dilation is the development of severe acute aortic incompetence. A sudden 
volume load, together with reduced coronary perfusion on the background of poor 
ventricular function or hypertrophy can rapidly lead to hypotension and acidosis despite 
prompt resuscitative measures. Three patients with severe aortic incompetence died 
after cardiac catheterization: two died after emergency surgery; and one whose valve 
incompetence was slightly less severe (ratio of echocardiographic regurgitant jet width 
to aortic annulus diameter of 0.9) died after attempted repair at 5 weeks of age. These 
results emphasize the importance of avoiding acute severe aortic incompetence in 
infancy, a situation that can rarely be successfully salvaged in the operating room.
 
In contrast, only two patients developed moderate aortic incompetence after an 
anterograde approach, although the ratio of balloon to annulus diameter was the same 
for both groups. No patients died in this group. Crossing the aortic valve in an 
anterograde fashion allows the wire to be advanced through the hemodynamic valve 
orifice and, together with the use of floppy-tipped guide wires, can reduce the risk of 
valve leaflet perforation. We speculate that it is this inadvertent valve perforation and 
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subsequent dilation that led to severe aortic incompetence (Fischer et al., 1990) in the 
present series but emphasize that this group of patients reflects procedures undertaken 
early in the overall experience.
Mitral incompetence. There was no progression of mitral valve incompetence after the 
retrograde approach. However after the anterograde approach, two patients developed 
moderate regurgitation which appeared to improve with time. Nevertheless, the 
anterograde approach to the mitral valve does carry potential risks of damage to the 
mitral valve apparatus. The catheter and wire may pass between chordae, resulting in 
injury to the tension apparatus when the balloon is withdrawn. Such injury may be 
avoided by utilizing an end-hole catheter to traverse the mitral valve in an effort to 
avoid the tension apparatus before achieving final wire position. If the total balloon 
length including taper is too long, it may also cross and potentially damage the anterior 
mitral valve leaflet during inflation. Looping and hand shaping the guide wire towards 
the apex of the left ventricle may help to avoid the mitral tension apparatus and reduce 
the potential for the guide wire to simultaneously prop open both the mitral and aortic 
valves, resulting in a marked reduction in forward flow. Hypoplastic ventricles may be 
more prone to these events but in any case should probably be excluded from 
consideration of balloon angioplasty. Although echocardiography during the procedure 
may help to identify an improperly placed wire across the mitral valve, this is not our 
current practice in the catheterization laboratory.
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Arterial complications. A significant difference in morbidity was seen in arterial 
complications. The incidence of femoral artery thrombosis was 62% (n=8) when the 
arterial access was used and only 11% (n=1) with an anterograde approach. This latter 
case was early in the experience and was unrelated to the technique. Previously reported 
series (Vogel et al., 1989; Burrows et al., 1990) also report a high incidence of arterial 
complications when the femoral artery was used for vascular access. No neurological 
sequelae were seen after anterograde balloon dilation, although a thrombus within the 
left atrial appendage did develop in the smallest patient. This occurrence can be 
lessened by systemic heparinization. Avoidance of direct manipulation of the carotid 
artery removes the potential for acute and long-term neurologic sequelae due to vessel 
compromise.
 
In all but the first two attempted anterograde dilations, the valve was successfully 
crossed and dilated. Significant reductions in systolic pressure gradients were achieved 
with improvement in left ventricular function, when impaired. No deaths occurred, and 
there was a low incidence of mitral incompetence, only one arterial thrombosis and a 
single occurrence of thrombus in the left atrial appendage.
Conclusions 
Compared with retrograde balloon dilation of the aortic valve, the anterograde approach 









Balloon dilatation has largely been accepted as the treatment of choice for recoarctation 
of the aorta but is less well established in the treatment of native aortic coarctation 
despite similar results (McCrindle et al., 1996). Within the first year of life and 
particularly within the first month, the high restenosis rate and the rate of femoral 
arterial complications after balloon dilatation of aortic coarctation supports surgical 
repair as the preferred option (Mendelsohn et al.,1994; Rao et al., 1996; Fletcher et al., 
1995). In older patients, however, balloon dilatation of both native and aortic 
recoarctation has a higher success rate with a lower incidence of restenosis than in 
infancy (McCrindle et al.,1996; Mendelsohn et al.,1994; Rao et al., 1996; Fletcher et al., 
1995; Huggon et al., 1994; Hijazi et al., 1991; Hellenbrand et al., 1990; Anjos et al., 
1992) but there are concerns about acute aortic dissection (Hellenbrand et al., 1990; 
Balaji, Oommen and Rees, 1991) and the late development of aneurysms (Aydogan et 
al., 1995; Tynan et al., 1990). It is of note that aneurysm formation is an increasingly 
recognized complication after various types of surgical repair (Pinzon et al., 1991; 
Bromberg et al., 1989), particularly when the results are evaluated by routine magnetic 
resonance imaging (Parks et al., 1995).
Balloon expandable endovascular stents have a long history in the treatment of 
peripheral (Palmaz et al., 1988) and subsequently atherosclerotic (Serruys et al., 1994) 
coronary artery disease. Since 1989, stent implantation has been applied in congenital 
heart disease principally in the pulmonary arteries and systemic veins (O’Laughlin et 
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al., 1991). After balloon dilatation, vessel recoil may lead to restenosis. Stents prevent 
this and thus maintain the effectiveness of dilatation within these structures. In addition, 
the integrity of the vessel is maintained by preventing the extension of any vessel tears 
or dissection between vessel layers that may have occurred after balloon angioplasty. 
Some studies have already described the application of endovascular stents in the 
treatment of aortic coarctation or recoarctation (Bulbul et al., 1996; Cheatham et al., 
1998). While their use in younger children is limited by their ultimate maximum 
expanded diameter, their application in older children, adolescents and adults appears 
promising.
We report our experience of stent implantation in both native and postoperative 
coarctation of the aorta in older children and adults. In older patients with native 
coarctation or those postoperative patients who had no previous balloon angioplasty, we 
elected to proceed directly to stent implantation in order to reduce aneurysm risk. We 
wish to emphasize the role of staged dilatation in an attempt to further reduce the 
incidence of aneurysms that may still occur after stent implantation (Cheatham et al., 




Patient population: Between November 1983 and June 1998, 17 patients (3 female, 
14 male) underwent stent implantation for aortic coarctation and recoarctation. The 
median age at the time of stent implantation was 17 years (range 4.4 to 45 years) and 
the median weight was 61 kg (range 17 to 92 kg). Six patients had native coarctation 
and 11 had aortic recoarctation (Table 5). Of those with aortic recoarctation, the initial 
type of surgical repair was subclavian flap aortoplasty in 5, onlay Dacron patch repair in 
two, resection of coarctation with end to end anastomosis in three, and insertion of a 12 
mm conduit bypass graft in one. Of those initially repaired by subclavian flap 
aortoplasty, one had also undergone balloon dilatation of recoarctation followed by 
Dacron patch repair and subsequently implantation of a conduit from the left common 
carotid artery to the descending aorta. This patient has been described in an earlier case 
report (Huggon et al., 1994).
One patient had two previous balloon dilatations; two had one previous balloon 
dilatation, and one had resection of recoarctation with end to end anastomosis followed 
by balloon dilatation. Two of the three patients who initially had repair by resection of 
coarctation with end to end anastomosis and one of the two patients who previously had 
repair by Dacron patch also underwent unsuccessful ballon dilatation. Therefore 23 

















BD x 1 160/50 Captopril/nifedipine/
atenolol
2 29 67 COA, AS SC Flap, 
E/E, AVR
BD x 1 160/90 Nifedipine/Aldactide
3 35 92 COA E/E None 160/100 None
4 6 20 COA, AS None None 138/88 None
5 8 22 COA SC Flap BD x 2 115/66 Atenolol
6 16 75 COA Dacron 
patch
None 146/69 None
7 24 57 COA Dacron 
patch
BD x 1 145/80 None
8 10 17 COA, 
supra AS
None None 158/80 None
9 43 58 COA, AS None None 140/70 None
10 45 74 COA, AS None None 155/85 None
11 45 83 COA None None 180/110 None
12 26 64 COA None None 156/74 None
13 8 28 COA E/E BD x 1 120/70 Propranolol
14 18 62 COA, TOF Conduit None 160/80 Enalapril/nifedipine/
acebutolol
15 16 67 COA SC Flap BD x 1 155/100 Enalapril/nifedipine
16 4 19 COA E/E BD x 1 150/90 Nifedipine
17 13 45 COA SC Flap BD x 1 190/105 Amlodipine/
perindopril
Table 5. Patient details. Key: AS, aortic stenosis; AVR, aortic valve replacement; BD, balloon 
dilatation; BP, blood pressure; COA, coarctation of the aorta; E/E, resection end to end 
anastomosis; SC Flap, subclavian flap aortoplasty; Supra AS, supravalve aortic stenosis; TOF, 
tetralogy of Fallot.
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Four patients also had additional aortic valve stenosis, one of whom had previous 
mechanical aortic valve replacement and two had undergone aortic valve replacement 
using pulmonary autografts after having had the coarctation treated with stent 
implantation. One patient had moderate aortic stenosis, which had not required 
treatment at the time of writing. One patient had Williams syndrome and mild 
supravalvar aortic stenosis. One patient had previous repair of tetralogy of Fallot and a 
double aortic arch. This patient was later noted to have a long segment coarctation 
which had been treated by the insertion of a 12 mm conduit bypass graft. 
Indications for intervention: All patients had reduced femoral pulses and Doppler 
echocardiographic evidence of coarctation of the aorta. Fourteen patients had evidence 
of resting upper limb systolic hypertension (systolic blood pressure > 95th centile for 
age) and six of these also had significantly raised diastolic pressures (> 95th centile 
for age). The remaining three were normotensive, but one had evidence of significant 
aortic stenosis requiring treatment  and the remaining two were on antihypertensive 
drugs. The blood pressures had been measured supine during outpatient clinic visits 
using standard mercury sphygmomanometers. Eight patients were receiving 
antihypertensive treatment with either a single drug (3 patients) or a combination of 
drugs (5 patients) before intervention.
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Stent implantation technique: Written informed consent was obtained from the 
patients-or in the case of children, from their parents-for the procedures, all of which 
were performed under general anaesthesia. 
Percutaneous entry was made into the femoral artery for angiography, as well as for the 
measurements of the ascending and descending aortic pressures and pullback gradients 
across the coarctation site. For stent delivery, percutaneous puncture was made into the 
contralateral femoral artery in 13 of the patients and a cutdown was performed onto the 
right common carotid artery in the remaining four. In these four youngest patients, a 
carotid artery approach was chosen in view of the diameter of the long introducing 
sheath required for stent deployment. Following the measurement of a pullback pressure 
gradient, an arch aortogram was performed (Fig. 21A) and the diameters of the 
transverse arch, minimum diameter of the coarctation site, and the diameter of the 
descending aorta at the level of the diaphragm, together with the length of the narrowed 
segment, were measured using electronic calipers. The measured catheter diameter or 
the 1 cm divisions on a ‘marker’ catheter (USCI Inc, Billerica, Massachusetts, USA) 
were used to correct for magnification. The angiographic catheter was left across the 
coarctation site for check angiography to aid positioning of the stent and was withdrawn 
just before deployment of the stent. Palmaz ‘iliac stents’ (7 x 308, 9 x 4014, 2 x 5014: 
Johnston and Johnston, Warren, New Jersey, USA) were manually crimped onto a 
variety of balloons (12 Olbert: Boston Scientific, Watertown, Massachusetts, USA; four 
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Cristal: E Merck Inc, Montmorency, France; one Blue-Max: Boston Scientific; and one 
Powerflex: Cordis Europa, Roden, Netherlands).  
After dilating the site of arterial access, an 11 F Mullins long transeptal sheath (Cook 
Europe, Bjaeverskov, Denmark) was advanced over an Amplatz SuperStiff guidewire 
(Meditech, Watertown, Massachusetts, USA) through the femoral or common carotid 
artery and across the coarctation site. Depending on the diameter of the balloon on 
which the stent was to be mounted, it was occasionally possible to use a smaller sheath, 
for example 9F. The stent/balloon assembly was then advanced through the sheath to the 
desired site. After a final check angiogram, both the angiographic catheter and the 
sheath were withdrawn to uncover the stent, and the balloon was inflated using an 
Indeflator. In the first three patients stents were fully expanded to the diameter of the 
normal vessel on either side of the coarctation, but in subsequent patients care was taken 
not to fully expand the balloon, or else an undersized balloon was chosen intentionally 
in order to reduce the likelihood of aortic wall damage. After the stent was deployed, 
simultaneous pressure measurements were made using the angiographic catheter and the 
delivery sheath, and a further aortogram was performed (Fig. 21B). At the conclusion of 
the procedure, the carotid artery cutdown sites were repaired and haemostasis obtained.
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Figure 21. (A) Long axis aortogram using a ʻmarkerʼ pigtail catheter showing discrete native 
coarctation in a patient who also had severe aortic valve stenosis. (B) Repeat aortogram 
following expansion of a Palmaz 4014 stent using an 18 mm ʻCristalʼ balloon. The stent is 
partially covering the origin of the left subclavian artery.
Antibiotics were given one hour before stent implantation and continued for 48 hours 
afterwards. A heparin bolus of 50-100 units/kg was injected intravenously following 
establishment of arterial access and continued as an infusion of 15-30 units/kg/hour for 
48 hours after the end of the procedure, to maintain an activated clotting time of over 
200 seconds. All the patients received an antiplatelet dose of aspirin (3-5 mg/kg/day) 
beginning on the day after the procedure and continuing for six months. In addition, 
four patients were fully anticoagulated with warfarin including the patient with the 
mechanical aortic valve, and the three patients at the start of the series.
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Follow up investigations: All except one patient underwent evaluation with spiral 
computed tomography between 2 days and 46 months after stent implantation (median 
interval 7.5 months). The early scans were performed in the two patients proceeding to 
aortic valve replacement. Helical CT acquisition was performed during single breath 
holding with a 3 mm slice thickness and a pitch of 1.66 (Fig. 22A). Axial images were 
reconstructed at 2 mm increments and used to generate high quality multiplanar 
reformatted three dimensional images (Fig. 22 B). during acquisition, 150 ml of 
intravenous non-ionic contrast medium (Ultravist 240 mg/ml) was administered at a rate 
of 3 ms/sec.
Figure 22. (A) Follow up spiral computed tomography (CT) with contrast showing stented aorta 
in cross section.(B) Axial three dimensional reconstruction of CT images in the same patient 
showing no evidence of aneurysm formation.
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Seven patients underwent repeat cardiac catheterisation. The indications for second 
catheterisation were clinical evidence of recoarctation in one patient, continuing 
hypertension in four, and the presence of an aneurysm on computed tomography in one. 
The remaining patient, a 10 year old boy, underwent a second elective catheterisation  a 
year after the initial stent procedure to dilate the stent further.
Statistics!
Results are given as medians with ranges or as means with 95% confidence intervals 
(CI). Comparisons were made using the paired Student t test. A p value of < 0.05 was 
considered significant.
Results
Immediate results: Eighteen stents were implanted during 18 procedures in 17 
patients (Table 6). The mean peak systolic pressure gradient fell from 26 mmHg (95% 
CI, 21 to 31 mmHg, range 12 to 55 mmHg) before to 5 mmHg (95% CI, 2 to 8 mm Hg, 
range 0 to 20 mmHg) after stent implantation (p < 0.001), and the mean minimum aortic 
diameter increased from 7 mm (95% CI, 6 to 8 mm, range 2 to 10 mm) before to 11.3 
mm (95% CI, 10 to 12.6 mm, range 7 to 16 mm) after stent implantation (p < 0.001). 
The mean ratio of the expanded stent diameter to the transverse aortic arch diameter 
was 0.75 (95% CI, 0.67 to 0.83) and the mean ratio of the expanded stent diameter to 
the descending aorta diameter was 0.76 (95% CI, 0.7 to 0.82). The peak systolic 
gradients were > 20 mmHg under general anaesthesia in 13 patients (76%) before
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1 6.4 11.3 12.0 11.9 1.05 0.99 40 0 Yes
2 10.1 20.0 22.0 12.8 0.64 0.58 12 0
3 9.1 19.1 21.5 14.0 0.73 0.65 17 10
4 7.4 16.0 14.4 13.6 0.85 0.94 13 0
5 5.1 11.3 10.4 7.4 0.65 0.71 34 20 Yes
6 8.8 18.5 13.9 11.0 0.61 0.78 20 10 Yes
7 8.3 11.0 13.0 10.5 0.95 0.81 13 5
8 5.3 11.4 8.8 7.0 0.60 0.8 20 0 Yes
9 7.0 18.4 16.2 13.2 0.72 0.81 20 0
10 10.3 30.0 22.0 16.0 0.53 0.73 25 2
11 7.9 22.4 16.2 13.3 0.59 0.82 31 0
12 4.5 16.5 14.2 12.0 0.73 0.85 23 0
13 4.3 10.0 10.0 7.4 0.74 0.74 30 2 Yes
14 2.0 16.0 12.0 10.0 0.63 0.83 55 10 Yes *
15 9.0 14.0 25.0 13.0 0.93 0.52 25 10
16 5.0 11.0 12.0 7.0 0.64 0.58 30 8
17 7.0 11.0 17.0 12.0 1.09 0.71 31 15
Table 6. Aortic measurements and results of stent implantation,*second stent implanted.
stent implantation, and between 10 and 20 mmHg in the remainder. The median 
fluoroscopy time for the procedure was 17.5 minutes (range 12.4 to 39 minutes). 
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Complications: Procedure related complications occurred in five patients. The early 
complications included a groin haematoma in one, haemorrhage from the carotid 
arteriotomy site requiring further surgical repair in one, and stent migration during 
deployment in two. There were no other vascular complications at the site of arterial 
access. The late complication of a small aneurysm related to the stent occurred in one 
patient.
Stent migration during implantation occurred in two patients with recoarctation of the 
aorta after previous subclavian flap repair. In both, the narrowest segment of the aorta 
was just distal to the origin of the left common carotid artery beyond which the aorta 
widened at the site of subclavian flap repair site to 18 mm diameter in the first patient 
and to 35 mm diameter in the second. Palmaz P308 stents were used in both patients. In 
the first patient, the stent slipped during expansion using a 12 mm balloon and 
embolised to the abdominal aorta where it was expanded further to 16 mm diameter 
where it remained. A further P308 stent was then placed across the coarctation site, 
expanded using a 14 mm balloon and the proximal and distal ends further expanded 
using a 16 mm balloon. In the second patient, the stent slipped back over the balloon 
just after expansion. The balloon was re-inflated to 14 mm inside the stent, the assembly 
was readvanced across the coarctation site and the balloon expanded further to 16 mm 
(equivalent to the diameter of the transverse arch), after which the stent remained in 
position.
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Formation of a small aneurysm was detected at angiography six months later in one 
patient (no. 14). This patient had a long segment coarctation of 2 mm diameter 
previously treated by a conduit bypass graft and had a systolic pressure gradient of 55 
mmHg. A P4014 Palmaz stent was expanded to 12 mm with a good immediate 
angiographic result. Late angiography performed because of a residual systolic pressure 
gradient of 30 mm Hg, showed an aneurysm at the midpoint of the stent. At that time a 
further P5014 stent was implanted overlapping the initial stent in an attempt to prevent 
extension of the aneurysm. Serial computed tomography over the next two years has 
shown no increase in the size of the aneurysm.
Follow up results
Spiral computed tomography 
Computed tomography was performed at least once during follow up in 16 patients after 
the initial procedure and apart from the one patient mentioned above, none had 
aneurysm formation. All the scans showed continued patency of the stent and of any 
head and neck vessels with origins partly covered by the stent (Fig. 23).
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Figure 23. Three dimensional reconstruction of spiral computed tomography images with 
contrast taken nine months after stent implantation in the patient shown in Fig. 1. The stent has 
been outlined in a different shade of grey from the aorta. Note continued patency of the left 
subclavian artery.
Recatheterisation and stent redilatation 
Recatheterisation was performed in seven patients after a median interval of 11.3 
months (range 6 to 35 months) from the initial procedure. In five patients, further 
balloon dilatation was performed with reduction of residual peak systolic pressure 
gradients from a mean of 15 mm Hg to a mean of 2 mm Hg and three of these patients 
have since undergone spiral computed tomography with no evidence of aneurysm 
formation. In one patient, a gradient of only 6 mm Hg was found at recatheterisation 
and reintervention was not performed. The remaining patient, who had the aneurysm, 
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has had two recatheterisations, at 9 months and 17 months after the second stent 
implantation. On each occasion, the peak systolic gradient across the stented area was 
35 mm Hg; however, as the aneurysm was still present, albeit small, no further 
intervention was performed.
Blood pressure 
No patients had acute hypertensive crises immediately after stent implantation. At the 
most recent follow up, eight patients were nomotensive and were not receiving any 
treatment (including two patients who had previously been treated with antihypertensive 
drugs). One untreated patient had borderline systolic hypertension (152/62 mmHg). 
Eight patients were still on antihypertensive treatment which consisted of one drug in 
five patients and a combination of drugs in three. One of these patients still had 
borderline systolic and diastolic hypertension (150/95 mmHg).
Discussion
The choice of treatment of aortic coarctation and recoarctation is between balloon 
dilatation and surgery using several different techniques. Each type of treatment is 
associated with a variety of complications. While balloon dilatation may produce good 
results in around 60-75% of the patients (Bulbul et al., 1996), it is associated with a low 
but important incidence of aneurysm formation. On theoretical grounds, therefore, it 
was felt that stent implantation would avoid aneurysm formation. In our series, stent 
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implantation has been shown to be effective in acutely reducing the pressure gradient, 
but it was still associated with aneurysm formation, albeit with a lower incidence. In 
hypertensive patients, the upper limb blood pressures are brought under control more 
easily, although continued antihypertensive treatment is often required. Follow up 
computed tomography showed continued patency of the stents, and no new aneurysm 
formation was noted even after redilatation of the stents. In the rare clinical situation of 
aortic coarctation combined with aortic stenosis, treatment of the coarctation with stents 
may have an important role. In this, stent implantation avoids the operative hazards of 
treating both conditions surgically (Pethig et al., 1996) and makes subsequent aortic 
valve surgery more straightforward. We encountered a low incidence of complications 
at the level of vascular access. Patients who underwent a surgical approach from the 
carotid artery should have ultrasound angiography of the cutdown site at a later 
date. 
We did not attempt to compare the results obtained with stent implantation with either 
surgery of balloon angioplasty techniques, in particular in the patients with aortic 
recoarctation. However, many of these patients had already undergone unsuccessful 
previous surgical or balloon angioplasty procedures. 
Surgery in this situation may be technically more difficult, may often involve the use of 
patches or conduits, and runs a potential risk of causing compromise to the spinal blood 
supply. Surgical repair using synthetic patches is fraught with serious complications 
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such as a high incidence of aneurysm and late death from aneurysm rupture (Knyshov et 
al., 1996). While balloon dilatation may be considered to be better than surgery, there is 
a high proportion of cases (25%) with a suboptimal outcome as defined by a residual 
gradient or major complications (McCrindle et al., 1996). In that large series of 907 
patients, these complications included death (0.7%), transmural aortic tear (0.7%) and 
stroke (0.6%).   
The mechanism of successful balloon dilatation of coarctation involves tearing of the 
aortic intima and media. In vitro histological studies (Lock et al., 1982; Ho et al., 1988) 
and in vivo studies by intravascular ultrasound (Ino et al., 1998; Harrison et al., 1990) 
have confirmed this mechanism. However, it is impossible to control the extent of the 
tearing which may extend transmurally. In addition, no safe upper limit has been 
defined for the required balloon diameter in relation to any aortic diameter 
measurement. Thus there will inevitably be a risk of aneurysm formation with balloon 
dilatation. In contrast, during stent implantation it is not necessary to over-dilate the 
coarcted segment to produce a good and predictable result. In addition, the stent can 
buttress the aortic wall, thus preserving its integrity and preventing the extension of any 
tears that may be produced. However, in spite of this aneurysm formation was 
encountered in one patient who had an unusually long segment coarctation. It is 
91
possible that this resulted from overdilatation of the narrow segment from 2 mm to 12 
mm. In another study of stent implantation for aortic coarctation/recoarctation 
(Cheatham et al., 1998), the incidence of aneurysm formation was 13%. Following this 
complication in our series, we have modified our policy to adopt an approach of 
performing a staged dilatation. Thus the balloon is either not fully inflated to the 
diameter of the adjacent measured normal vessel at the time of stent implantation, or a 
smaller sized balloon is chosen. If necessary, a further dilatation is performed after six 
to 12 months in order to achieve complete expansion of the stent. In five of 17 patients 
in our study, redilatation of the stents was successfully achieved without any 
complications. If and when a significant aneurysm develops, a covered stent could be 
implanted. We are aware of covered stents having been used in adult patients with 
abdominal aortic aneurysms and thoracic aortic dissection. 
Redilatation of stents in animal models of coarctation has produced conflicting results. 
Morrow et al. (1994) re-expanded stents in five animals and noted compression of the 
media beneath the struts but no evidence of dissection of the intima or media. However, 
Mendelsohn et al. (1996) encountered aortic rupture and death in two of seven animals 
at redilatation.  To our knowledge, aortic rupture has not occurred during redilatation of 
the aortic stents in humans. Improvements in stent design including rounding of sharp 
edges or even the use of absorbable materials which might further lower the risk of such 
tramsmural damage during both dilatation and redilatation. The avoidance of 
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pre-dilatation with a balloon just before stent implantation may also reduce the risk of 
aortic damage.
Successful balloon dilatation of both native (Schrader et al., 1995) and recurrent 
coarctation (Witsenburg et al., 1993) of the aorta can bring upper limb hypertension 
under control in the medium term, even in adult patients. In our series, the patients were 
often hypertensive before stent implantation in spite of combinations of anti-
hypertensive drugs. In the medium term, blood pressure has either normalized or has 
been easier to control with a more simplified drug regime. There is a theoretical concern 
that aortic stents may cause increased aortic wall impedance (Xu et al., 1997) and 
therefore systolic hypertension during exercise, but such a mechanism may occur in the 
post surgical aorta owing to scar formation or patch aortoplasty.
One further theoretical concern might be the compromise of blood flow to small side 
branches arising from the aorta, particularly those supplying the spinal cord. Continued 
patency of side branches in the coronary circulation has been demonstrated after stent 
implantation (Schatz et al., 1987) and here have been no reports of spinal cord damage 
after aortic stent implantation thus far. 
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Conclusion
Stent implantation for aortic recoarctation and native coarctation is successful in older 
children and adult patients and the acute results are encouraging. Upper limb blood 
pressure can be brought under improved control although some patients continue to 
require antihypertensive treatment. Short term follow up shows continued relief of 
stenosis with a low incidence of complications but longer follow up is necessary.
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Aortopathy
Part 2: Combined interventional and surgical 
management of aortic stenosis and coarctation. 
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Introduction
Athough a bicuspid aortic valve is a common finding in association with coarctation of 
the aorta (Becker, Becker and Edwards, 1970), the combination of significant aortic 
stenosis and coarctation of the aorta appears to be much less common outside the setting 
of hypoplastic left heart syndrome. In children, aortic valve stenosis has been reported 
in 7% of a large group undergoing balloon angioplasty of native coarctation of the aorta 
(McCrindle et al., 1996). In adults, severe aortic valve stenosis has ben reported in 4% 
of those with aortic coarctation or following resection of coarctation (Turina et al., 
1997). When this combination arises, the possible surgical options consist of either a 
two-staged surgical approach (Turina et al., 1997) or a one-stage surgical repair 
combining aortic valve replacement with the insertion of a Dacron graft from the 
ascending to the descending aorta (Bartoccioni et al., 1995; Thomka, Szedo and Arvay, 
1997).
We report 2 patients,who underwent implantation of an endovascular stent for 
coarctation of the aorta as an initial procedure followed within 2 weeks by aortic 
valve replacement using pulmonary autografts (Gonzalez-Lavin et al., 1970). Spiral CT 
scanning was performed prior to the valve replacement to confirm the absence of aortic 
aneurysm following stent implantation.
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Case histories
Patient 1: Clinical evidence of significant aortic valve disease was discovered 
incidentally in a normotensive 42 year old man during an accident and emergency 
attendance. A cross-sectional echocardiogram revealed left ventricular hypertrophy and 
a Doppler estimated gradient of 70 mmHg across the aortic valve together with a 
suspicion of aortic coarctation. Cardiac catheterization confirmed calcific aortic 
stenosis, additional discrete coarctation of the aorta with a peak systolic pressure 
gradient of 30 mmHg and normal coronary arteries. For 2-3 months prior to admission 
for surgery he began to experience dyspnoea on exertion. 
Patient 2: A 44 year old man was found to have a heart murmur in infancy but was not 
investigated and remained asymptomatic. During an employment medical, he was found 
to have borderline hypertension (BP 155/85 mmHg) and a loud murmur was heard. He 
was referred for echocardiography which showed the combination of moderate aortic 
stenosis (Doppler estimated systolic gradient of 60 mmHg and a tight coarctation of the 
aorta (Doppler estimated systolic gradient of 50 mmHg). Cardiac catheterization 
showed normal coronary arteries and confirmed a discrete coarctation of the aorta.
Procedures
Stent implantation: After obtaining written informed consent, the procedures were 
performed under general anaesthesia with percutaneous entry via the femoral arteries. 
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Systolic pressure gradients across the coarctation site were 25 mmHg and 30 mmHg and 
angiography revealed a discrete coarctation of the aorta in both patients with minimum 
diameters of 7 mm and 10 mm. The diameters of the adjacent aorta above and below the 
coarctation sites were 25 mm and 16 mm in the first patient and 17 mm and 20 mm 
respectively in the second patient.
Full anticoagulation with 100 units/kg of heparin and antibiotics (gentamicin and 
flucloxacillen) were administered prior to stent implantation. After dilating the site of 
femoral venous access, an 11 Fr. Mullins long trans-septal sheath (Cook Europe, 
Denmark) was advanced over an Amplatz Superstiff guidewire (Meditech, Watertown, 
Mass. USA) previously placed across the coarctation site. A 4014 ‘Palmaz’ iliac stent 
(Johnson and Johnson, Warren, NJ) was mounted and hand crimped onto an 18 mm 
Cristal angioplasty balloon (E Merck Inc., Montmorency, France) and advanced through 
the long sheath to the desired position. After check angiography, both the angiographic 
catheter and the sheath were withdrawn to uncover the stent and the balloon was 
inflated using an inflation device. Care was taken not to expand the stent fully to the 
diameter of the adjacent aorta. After stent deployment, simultaneous pressures proximal 
and distal to the stent were measured using the angiographic catheter and the delivery 
sheath, and a further aortogram was performed (Fig. 24). There were no residual 
gradients and the narrowest aortic diameters had increased to 13 mm and 16 mm 
respectively. At the conclusion of the procedure haemostasis was achieved by direct 
manual pressure. There were no complications in either patient.
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Figure 24. Aortogram (A) in a right anterior oblique projection showing a discrete coarctation of 
the aorta just distal to the left subclavian artery in patient 1 who also had severe calcific aortic 
stenosis. After stent implantation, (B) there is a substantial increase in the minimum vessel 
diameter with abolition of the pressure gradient.
Heparin infusion was continued for 48 hours following the procedure to maintain an 
activated clotting time of 200 seconds and antibiotics were continued over the same 
period. An anti-platelet dose of aspirin (3-5 mg/kg) was commenced on the day after the 
procedure for 6 months. Spiral CT scanning was performed at 3 and 6 days respectively 




Aortic valve replacement: Both patients underwent aortic valve replacement using 
pulmonary autographs 7 and 15 days respectively after stent implantation within the 
aortic coarctation. The pulmonary roots were reconstructed using 24 mm pulmonary 
homografts. In the second patient the right coronary button disintegrated during the 
operation, and a short segment of the long saphenous vein was therefore harvested and 
anastomosed to the stump of the proximal right coronary artery with the proximal end 
of the graft being anastomosed to the ascending aorta. Both patients were weaned from 
cardiopulmonary bypass uneventfully. However the second patient had problems with 
needle point haemorrhage in the operating theatre and also developed a large pleural 
effusion several days after surgery which required drainage.
At the most recent follow-up visit (9 months after the valve replacement) both patients 
are well with normal arm blood pressure. Repeat spiral CT scanning has also been 
performed in both patients at 9 and 6 months respectively after surgery with no 
evidence of aortic aneurysm formation.  
Discussion
The combination of significant aortic stenosis and coarctation of the aorta can present a 
significant challenge in the adult population. When valve replacement is performed first 
as part of a staged approach there is a potential for difficulty in re-establishing the 
patient’s circulation in the face of persistent left heart obstruction. A single stage 
approach involving trans-pericardial bypass of the coarctation has evolved as it may be 
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difficult to reach the coarcted segment from the midline. When such an approach is 
employed, difficulty in weaning from cardiopulmonary bypass has been reported 
(Pethig et al., 1996). Therefore non surgical treatment of the coarctation could offer a 
significant advantage. Stent implantation has been successfully performed in older 
children and adults with both native and recurrent coarctation of the aorta (Bulbul et al., 
1996). Although it should theoretically reduce the risk of transmural tears and aneurysm 
formation when compared with balloon angioplasty alone it does not abolish the risk of 
aneurysm formation entirely. Therefore careful evaluation by CT scanning is necessary  
before proceeding to cardiopulmonary bypass. 
Conclusion
Two stage combined interventional and surgical management of aortic stenosis and 
native coarctation of the aorta was performed successfully in 2 patients. To our 
knowledge this approach has not been previously described. Both patients were easily 
weaned from cardiopulmonary bypass and remain well at latest follow-up. Neither 
patient has developed any evidence of aortic aneurysm formation related to the stent and 
both remain normotensive. While continued follow-up is necessary we believe this 




Balloon expandable stent implantation for superior 
vena caval obstruction following surgical repair of 




Partial anomalous pulmonary venous drainage (PAPVD) accounts for 0.5% of 
congenital cardiac defects (Martinez-Jimenez et al., 2010). It most commonly involves 
the right upper pulmonary vein and usually coexists with a sinus venosus atrial septal 
defect (Oliver et al., 2002). Physiologically the effect is identical to any shunt at atrial 
level, the right heart will dilate producing breathlessness on exertion in adult life and 
some patients will go on to develop atrial arrhythmias and pulmonary hypertension 
(Webb and Gatzoulis, 2006). Surgical repair is usually performed by inserting a patch of 
autologous pericardium to direct flow from the pulmonary vein or veins across the atrial 
defect and into the left atrium (Gaynor et al., 1995). The caval to atrial junction may 
then be patch enlarged to prevent stenosis. The more superiorly the pulmonary vein 
enters the superior vena cava (SVC) the greater the chance of producing caval or 
pulmonary vein stenosis because of the smaller available SVC lumen (DeLeon et al., 
1993). An alternative is to use the Warden technique (Warden et al., 1984) when the 
SVC is transected and oversewn above the anomalous pulmonary vein or veins and then 
coapted or baffled across the atrial septum to the left atrium (Fig. 25). Normal SVC-
right atrial flow is reconstituted by anastomosis of the cephalad portion of the transected 
SVC to the right atrial appendage. Surgery is often delayed following diagnosis in 
smaller children to reduce the risk of venous obstruction.
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Although the Warden technique should lessen the risk of obstruction to pulmonary 
venous return it does not completely remove the risk of superior vena caval obstruction 
(Tzifa et al., 2007). 
Figure 25. Diagram of Warden procedure for repair of partial anomalous pulmonary 
venous return from Sogat V, Sagat M, Balazova E, Siman J. (2008) Outcomes after surgical 
repair of sinus venosus atrial septal defect in children. Bratislava Medical Journal,109, 215-219.
Patients with SVC obstruction often present with headaches and facial puffiness 
especially in the morning, shortness of breath is a frequent finding however a number 
are asymptomatic and only diagnosed incidentally (Tzifa et al., 2007). On examination 
there might be evidence of SVC syndrome with upper body venous 
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congestion and facial oedema. 
Three patients developed SVC obstruction following surgical repair of partial 
anomalous pulmonary venous drainage. The acute and medium term results of stent 
implantation are presented.
Patients and methods
Patients: From the total congenital surgical database, 3 patients were identified over a 
10 year period who presented with symptoms of headaches and also had 
echocardiographic evidence of SVC obstruction (Table 7), weights ranged 
from12.9-24.3 kg. Conventional repair had been performed in 2 patients and a Warden 
procedure in one. 
Methods: All catheter procedures were performed under general anaesthesia with 
percutaneous entry into the right femoral vein. In one patient the right internal jugular 
vein was also entered for monitoring purposes. Pressures were measured above and 
below the stenoses and well as in the pulmonary arteries. Angiograms were performed 
in antero-posterior and lateral projections (Fig. 26). In the first patient a 10 mm Cordis 
OPTA balloon (Johnston and Johnston, Warren, NJ, USA) was placed across the 
stenosis and dilated to 5 atmospheres with recoil of stenosis. This patient then 
underwent stent implantation using a 39 mm Palmaz Genesis stent over an 8 mm Blue 
Max balloon (Boston Scientific, Mn, USA) which was further dilated to 12 mm using a 
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Cristal balloon (Balt, Montmorency, France).  Care was taken to cover the narrowest 
portion of the SVC by implanting the stent using roadmaps from the lateral projection. 
Based on this experience, the other 2 patients went directly to stent implantation using 
29 mm and  39 mm Palmaz Genesis stents over 12 mm Cordis OPTA balloons. 
All procedures were performed uneventfully. Mean gradients fell from a median of 10 
mmHg (range 7-17) to 0 mmHg (range 0-1 mmHg) with minimum diameters increasing 
from median of 4.6 mm (range 2.5-5) to 9.6 mm (range 7.6-12) (Table 1). Following 
stent implantation, angiograms were performed in the right pulmonary arteries to look 
for evidence of hold up of contrast in the territory of the right upper pulmonary vein on 
the laevophase and none was seen. There were no increases in pulmonary artery 




Figure 26. Lateral SVC angiogram before (A) and after (B) stent implantation in patient 2. The 
initial angiogram is via the azygous vein, following implantation of a 29 mm long Genesis stent 












































































































Follow-up: The median duration of follow-up was 9.9 years (range 9.1-10). The first 
patient has had no further intervention, the most recent ECG shows sinus rhythm with a 
PR interval of 124 msec and echo shows a mean gradient of 2 mmHg across the SVC 
with no evidence of pulmonary hypertension. The second patient re-presented with 
headaches after 2.7 years and echocardiogram suggested narrowing at the lower end of 
the stent. At catheterization the lower end on the stent was narrowed to 8.5 mm 
compared to 11.5 mm superiorly. There was a pullback pressure gradient of 2-3 mmHg 
which was abolished with a single inflation of a 12 mm Cordis OPTA balloon. This 
patient has remained well with no further recurrence and the PR interval on latest ECG 
is 120 msec. The third patient had a further routine catheter procedure performed after 
6.5 years. The original Palmaz Genesis stent was found to be fractured in 2 places (Fig. 
27) and a further 2 overlapping Max LD stents (ev3 Endovascular, Plymouth MN, 
USA) were implanted uneventfully. A further cardiac catheter 2.6 years later showed 
continued evidence of normal SVC flow. ECG remains entirely normal.
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Figure 27. Lateral angiograms in the third patient 6.5 years after initial stent implantation (A) 
showing 2 stent fractures and (B) following implantation of 2 Max LD stents over 14 mm balloon 
with increase in minimum diameter from 9.3 to 10.7 mm .
Discussion:
The most common cause of superior vena caval obstruction in all ages is malignancy 
especially of bronchogenic origin (Rice, Rodriguez and Light, 2006). The second most 
common cause is the presence of an indwelling catheter and there appears to be an  
increasing frequency of SVC obstruction caused by the use of long term venous access 
(Funaki, 2006; Seelig et al., 1998) and pacemaker leads (Aryana et al., Chee, Bjarnason 
and Prasad, 2007).
110
In younger patients the pattern tends to be different. The largest reported series was of 
63 patients (Tzifa et al., 2007) with median age 3.7 years (range 1 month to 42 years), 
24 had previous atrial switch (Senning or Mustard) procedures for transposition of the 
great arteries, 12 had previous ECMO cannulation, 10 had previous PAPVD repair and 
9 had long term central venous catheters.
For malignant SVC obstruction, endovascular stents have become the treatment of 
choice (NICE guidelines, 2004) Previously non malignant SVC obstruction was treated 
using surgical techniques particularly saphenous vein grafts with good long term 
patency (Kalra et al, 2003) however increasingly angioplasty and stents are gaining 
acceptance. There are a number of reports of successful relief of stenosis using 
angioplasty alone (Strecker et al, 2014; Sogat et al, 2008) however this technique does 
carry a not insignificant risk of causing SVC tears (Tzifa et al., 2007) and in our 
experience appeared to be ineffective because of vessel recoil although balloon sizes 
chosen were conservative.  
The very first series of the use of balloon mounted stents in congenital heart disease 
from 1991 included one patient who had stenting of the SVC after repair of sinus 
venosus ASD (O’Laughlin et al., 1991). Stenting is now the treatment of choice for 
systemic venous baffle obstruction late after the atrial switch procedure (Bu’Lock et al., 
1998) and has even been described (in combination with transeptal needle perforation) 
in a series of patients following atrial switch where the superior baffle has become 
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completely blocked (Ebeid et al., 2005).  There are now very few patients having an 
atrial switch for simple transposition however with the development of the double 
switch procedure for congenitally corrected transposition of the great arteries (Reddy et 
al., 1997) there will continue to be some patients at risk of baffle obstruction. 
There are a few case reports (Nicolae, Radford and Slaughter, 2006) and one series 
(mentioned above) of stenting for SVC narrowing after repair of partial anomalous 
pulmonary venous drainage albeit with limited follow-up.
After repair of partial anomalous pulmonary venous drainage there is already the 
potential for rhythm disturbances related to damage to the sinus node or to its blood 
supply. A series of 85 patients from Bratislava over a 13 year period revealed a 28% 
incidence of arrhythmias including junctional rhythm, sinus node dysfunction and atrial 
ectopic tachycardia (Sogat et al, 2008). On this background, placing a balloon or 
balloon expanded stent across this area might further raise the chance of dysrhythmia.  
There is one case report of sinus arrest after stent implantation for SVC syndrome 
(Tempelhof, Campbell and Ilkannoff, 2014) however this was in an 80 year old and 
there was complete recovery within 48 hours. None of the patients in our series had any 
PR prolongation on ECG but it is important to mention the possibility of damage to the 
sino-atrial node during the consent process. 
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There is also the potential for SVC rupture during percutaneous stent treatment with a 
reported total of 4 cases including 1 death and 1 immediate pericardiocentesis followed 
by open surgical repair (Samuels, Nyzio and Entwhistle, 2007). Therefore, as with all 
percutaneous techniques, it is important to proceed with caution and have covered stents 
immediately available in case of a significant tear producing haemodynamic 
compromise. 
Conclusion
This small series of 3 patients with SVC obstruction after repair of partial anomalous 
pulmonary venous drainage shows effective obstruction relief using balloon expandable 




Discussion and future direction
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Discussion
The essential nature of congenital heart disease is the presence of a defect or defects in 
the macroscopic structure of the heart resulting from abnormal development thought to 
occur mostly within the first trimester of pregnancy (Neuman and Huhta, 2006). Around 
half of the approximately 8 per 1000 babies born with congenital heart disease (Van der 
Linde et al, 2011) will require treatment and this treatment has to take the form of a 
physical alteration to the structure of the heart and/or great vessels. Surgical treatment is 
now well established and outcomes continue to improve (Cunningham et al., 2013) both 
in terms of efficacy and safety however there is understandably a desire to provide 
treatment which minimizes the degree of disruption to the individual and their family. 
Even in the best hands cardiac surgery places a considerable catabolic load on the 
individual. This is particularly important in neonates and young infants (Costello et al., 
2014) and may have implications for future neurological development (Levitt, 2003). 
Therefore less invasive endovascular techniques have gained popularity both to 
augment and replace cardiac surgery. 
This thesis has explored how some obstructive congenital lesions can be treated using 
less invasive catheter methods with a particular emphasis on technique and materials. 
How have these treatments developed and what are the future directions?
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Baffle obstruction after the atrial switch: percutaneous stent implantation has become 
the treatment of choice for baffle obstruction after an atrial switch procedure for 
transposition of the great arteries (Bu’Lock et al., 1998). However the number of adult 
patients being followed post atrial switch is starting to dwindle as it is now 
approximately 30 years since the arterial switch was introduced. The more recent 
double switch procedure (Hiramatsu, 2012) for congenitally corrected transposition 
should mean a small number of patients will continue to at risk of baffle obstruction. 
The only situation where balloon angioplasty alone, as described in this thesis, might 
still be considered would for the patient with pacing wires in an obstructed superior 
baffle limb and an unacceptable risk of lead extraction. 
Cutting balloon angioplasty: The two main indications for this technique in  congenital 
heart disease are pulmonary vein stenosis and small vessel pulmonary artery stenosis. In 
addition, cutting balloons are sometimes used to enlarge communications in the atrial 
septum. A case series from 2006 (Seale et al., 2006) reported 27 stenosed pulmonary 
veins treated during 12 procedures in 6 patients with some symptomatic relief but no 
change in the Doppler derived right ventricular pressure. The relief was only temporary 
with the longest time before a repeat procedure being only 6 months. Pulmonary vein 
stenosis remains a disappointing lesion to treat with high recurrence rates and similarly 
poor results from stent implantation (Tomita et al., 2003). The biggest series of stent 
implantation did show a lower risk of reintervention when larger stents 
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over 7 mm in diameter are implanted (Balasubramanian et al., 2012) but this is rarely 
possible in smaller children.
The use of cutting balloons for small vessel branch pulmonary artery stenosis is more 
encouraging. A study from 2002 of small vessel pulmonary artery stenosis resistant to 
conventional angioplasty during 4 catheter procedures showed significant increases in 
vessel diameter which persisted at follow-up catheter after a median interval of 14 
months (Rhodes et al., 2002). This led to a multicentre randomised trial of cutting 
balloon therapy versus high pressure balloon therapy for resistant pulmonary stenoses 
(Bergesen et al., 2011). Seventy-three patients from 8 institutions were enrolled over a 4 
year period. In these patients, 72 vessels responded to low-pressure balloon dilation 
alone and of the remaining 173 vessels, 107 were randomised to cutting balloon and 66 
to high pressure balloon. Cutting balloon therapy was associated with greater percent 
increase in lumen diameter (85% versus 52%; P=0.004) in comparison to high pressure 
balloons with an equivalent safety profile.  
Balloon dilation of aortic stenosis: The potential advantages of an antegrade approach 
for balloon angioplasty of the aortic valve in children are firstly to lessen the chances of 
arterial vascular damage and secondly to reduce the risk of aortic incompetence by 
performing the procedure in the direction of blood flow to optimise balloon stability. As 
the risk of arterial vascular damage is greater in infants, this age group might derive 
particular benefit. This is set against the increased technical difficulty of this approach 
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especially in smaller hearts and the risk of damaging the mitral valve. Since the paper 
describing this approach was published in 1997, the use of rapid right ventricular pacing 
to improve balloon stability has become widely accepted (Daehnert, 2004). Also newer 
low profile balloons requiring smaller introducing sheaths are available. Therefore there 
is no longer such a requirement to consider the antegrade approach to the aortic valve.
 
A numbers of centres continue to advocate surgery over a catheter approach to treat 
aortic stenosis in children and this is one of the few lesions where there have been direct  
comparisons between the 2 approaches. It is known that aortic regurgitation tends to 
progress after either balloon dilation or surgical valvotomy (Justo et al., 1996). A study 
from the Congenital Heart Surgeons Society(McCrindle et al., 2001) in the 1990s of 110 
neonates with critical aortic stenosis showed that surgical and balloon valvotomy had 
similar outcomes. There was a greater likelihood of important aortic regurgitation with 
balloon valvotomy and of residual stenosis with surgery. To some extent the conclusions 
of these studies reflect authorship. A retrospective study going back 32 years from 2009 
of 123 consecutive infants showed better freedom from re-intervention after surgery
(Siddiqui et al., 2013).  However a study from Munich in 188 patients over 17.5 years 
(Fratz et al., 2008) showed that around two thirds of patients remained free of surgery 
10 years after catheter intervention. Therefore, as catheter intervention is able to 
significantly delay first surgery for aortic stenosis and as no surgical valve repair or 
replacement will last for a lifetime, catheter intervention does have a place in reducing 
the number of operations an individual with congenital aortic stenosis will require.
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Aortic stenosis covers a broad spectrum of disease and at the severe end merges with 
hypoplastic left heart syndrome when the left ventricle is not capable of sustaining the 
circulation. A very poor outlook for prenatally diagnosed aortic stenosis led to the first 
attempted intrauterine dilation of the aortic valve in 2 fetuses in 1991 (Maxwell, Allan 
and Tynan, 1991). One died in utero but in the other the valve was successfully crossed 
and dilated, the fetus was delivered and a further balloon dilation performed. This child 
lived for 5 weeks before dying from persistent left ventricular dysfunction. 
Although surgery for hypoplastic left heart syndrome subsequently became feasible, the 
possibility of successful fetal intervention became a driver to potentially alter the 
natural history of borderline hypoplastic left heart syndrome. It was felt that intervening 
on the valve in utero might prevent progression to endocardial fibrosis and ventricular 
hypoplasia and so increase the chances of a biventricular circulation. While there are 
some claims that this strategy is successful (Tworetzky et al., 2004) it is very difficult to 
predict which cases would have achieved a biventricular circulation in any case. At 
present, apart from a few centres in the US, this approach has not found widespread 
acceptance and is no longer attempted in the UK. 
Apart from balloon dilation of the aortic valve, is catheter intervention possible 
elsewhere in the left ventricular outflow tract in children? Certainly balloon dilation of 
supravalvar aortic stenosis, which is due to the elastin aortopathy found in William’s 
syndrome, is not to be recommended. The thickened vessel wall will not respond to 
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angioplasty and there is often coronary involvement with a degree of aortic valve leaflet  
adhesion to the narrowed sinotubular junction restricting diastolic filling of the coronary 
arteries (Stamm et al., 1997). Even sedation or anaesthesia for diagnostic cardiac 
cathterization carries a risk of sudden death (Burch et al., 2008). 
The causes of subvalvar aortic stenosis are: a fibromuscular ridge extending to the 
anterior leaflet of the mitral valve (Kelly, Wulfsburg and Rowe, 1972), a tunnel like 
muscular narrowing (Maron et al., 1976), accessory mitral valve cords (MacLean, Kane 
and Culligan, 1963), a combination of these factors as well as hypertrophic obstructive 
cardiomyopathy (Wigle, Heimbecker and Gunton, 1962). Interestingly attempts have 
been made to use catheters to treat discrete subvalvar aortic stenosis caused by a 
fibromuscular ridge. A study in 1990 showed temporary relief of obstruction (Rao, 
Wilson and Chopra, 1990) and one long term study from a single centre showed 
persistent benefit in 77% of 76 patients over a 25 year period (De Lezo et al., 2011). In 
spite of these results, surgery remains the treatment of choice as the stenosis is often 
closely related to the valve and alters blood flow dynamics resulting in valvar 
incompetence which might be exacerbated by angioplasty. Left ventricular outflow tract 
obstruction caused by asymmetrical septal hypertrophy found in hypertrophic 
obstructive cardiomyopathy is treated by percutaneous alcohol septal ablation in adults 
(Sigwart, 1995) but not in children because of the risks of septal rupture, heart block and 
ventricular arrhythmias (Yetman and McCrindle, 2005).
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Coarctation and recoarctation of the aorta: Stent implantation for coarctation of the 
aorta has become a firmly established treatment in older children and adults  and is 
being extended to treat complex and more proximal arch obstruction (Holzer et al., 
2008). The largest study of stent implantation was data from a prospective registry of 
302 patients in 32 centres over a nine year period showing procedural success in 96% 
(defined by less than 20 mmHg upper to lower systolic limb pressure gradient) which 
fell to 77% after 1.5 years (Holzer et al., 2010). Complications such as dissection and 
aneurysm formation were very uncommon, but 32% of patients continued to require 
antihypertensive medication and around 20% of the patients continued to have systolic 
blood pressure over the 95th centile. Coarctation of the aorta is associated with 
abnormal vascular reactivity and there is some suggestion that the rigid stented portion 
of the aorta might exacerbate this leading to systolic hypertension on exercise in spite of 
adequate relief of stenosis (Chen et al., 2008). While this does occur there appears to be 
no difference in exercise induced hypertension between patients treated by surgery or 
stent implantation (de Caro, 2010). 
Stent implantation for coarctation was also successful in a group of patients under 30 kg 
compared to older children (Mohan et al., 2009) but size of the patient does become a 
limiting factor when planning stent implantation due to the risk of vascular access 
damage and the maximum expandable stent diameter. Stents have been implanted in 
neonates as emergency bail out procedures when the risk of surgery was deemed too 
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high (Fink, Peuster and Hausdorf, 2000) but current available technology does not allow 
definitive treatment in infants and young children. 
Balloon expandable stent implantation for superior vena caval obstruction: As 
mentioned above stent implantation is well established for systemic venous pathway 
obstruction after atrial switch. Obstruction after repair of partial anomalous pulmonary 
venous drainage is rare although there will probably be an increasing need for this 
technology to treat superior vena caval stenosis due to indwelling catheters. Where 
covered balloon expandable stents might have a place would be in the creation of non 
surgical bidirectional cavopulmonary connections (Levi et al., 2009).
Future directions
To some extent it could be argued that the last 10 years have been a period of 
consolidation rather than progress in the treatment of native and acquired stenoses in 
congenital heart disease. The one major development has been the balloon mounted 
percutaneous valve to treat conduit dysfunction (McElhinney et al., 2010) in right heart 
disease. Although principally designed to treat pulmonary incompetence, there usually 
exists a combination of both stenosis and incompetence which can be effectively treated 
by valve implantation.
A major feature of how the treatment of congenital heart disease is evolving is the much 
younger age at which most major cardiac surgical procedures are being performed. This 
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challenges catheter technology to find ways to effectively and safely treat smaller 
patients. A good example is tetralogy of Fallot, one of the commonest forms of 
congenital heart disease with a prevalence of 0.26 per 1000 livebirths (Ferencz et al., 
1986). Although outcomes in terms of overall survival are good there is still debate on 
how to manage this condition in order to provide the best quality of life. Neonates with 
severe right ventricular outflow tract obstruction and a low birth weight can present a 
real management challenge. Previously insertion of an arterial to pulmonary artery 
shunt was used as palliation in this group until they were big enough to undergo 
complete repair however this palliation is far from simple. A study of 32 patients after 
modified Blalock-Taussig shunt insertion showed a 9% mortality (Dirks et al., 2013). 
Although not all suffering from tetralogy of Fallot, most of this group had biventricular 
hearts (n=21) and infants with hypoplastic left heart syndrome were excluded. Risk 
factors for an adverse outcome were lower body weight and bigger shunt size to body 
weight ratio. In addition, it is well known that pulmonary artery hypoplasia and 
distortion are common after Blalock-Tussig shunt palliation (Gladman et al., 1997). 
To get around these problems, investigators have initially attempted balloon angioplasty  
of the right ventricular outflow tract (Qureshi et al., 1988: Sreeram et al., 1991) which 
can be effective if obstruction is mostly valvar but often fails and can precipitate severe 
hypercyanotic spells. The next step was to implant stents in the right ventricular ouflow 
tract, a small case series (Gibbs et al., 1997) showed promise but it has taken some time 
before further positive evidence has emerged (Stümper et al., 2013). 
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The problem is that this strategy makes the next stage of definitive surgical repair more 
difficult, often part of the stent is firmly embedded in the muscle of the right ventricular 
outflow tract and cannot be entirely removed. Also, if the original stent is lying across 
the pulmonary valve annulus extending into the main pulmonary artery then progression 
to severe pulmonary regurgitation will be accelerated. 
Not only in tetralogy of Fallot but for many other congenital stenosis balloon 
angioplasty alone is often suboptimal. As mentioned above the problem with stents 
remains the maximum possible achievable diameter: for example in coarctation of the 
aorta a stent implanted in infancy would need to be dilated to 3 times implantation 
diameter to reach an adequate adult size. The two ways of dealing with this problem are 
bio-absorbable stents and a mechanical solution using stents which can be opened along 
their length during redilation. 
Bio-absorbable stents are of two types either composed of polymers or of metal which 
corrodes so called bio-corrosion. Looking at bio-corrosion, the metals studied have been 
either iron or alloys consisting mostly of magnesium. Implantation of iron stents in the 
descending aorta of rabbits (Peuster et al., 2001) showed continued stent patency and 
the absence of inflammation thrombosis or neointima at follow up. There was 
considerable iron staining of the tissues but and no evidence of iron toxicity. As yet 
there are no reports of the use of iron stents in children and it may be that the low rate of 
metal degradation means that the advantages in a growing child may not be met. An 
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alternative is magnesium which if anything can degrade too quickly. Biotronik have 
developed the AMS stent which is 93% magnesium and 7% rare earth metals. The first 
study in man with coronary disease showed high rates of vessel restenosis due to the 
very rapid degradation of the stent, however this behaviour can be modified by polymer 
coating of the stent (Gray-Munro, Seguin and Strong, 2009).
The first use of an AMS stent in congenital heart disease was by Zartner (2007) who 
placed an AMS stent into the left pulmonary artery of a 1.7 kg preterm baby using a 
hybrid surgical cutdown. At 4 months the stent had completely degraded and the left 
lung remained well perfused. The child died of pneumonia one month later and autopsy 
showed continued vessel patency with a smooth endothelial surface. A magnesium stent 
was also used to treat severe long segment recoarctation of the aorta after surgical repair 
(Schranz et al., 2006). The coarctation reoccurred as the stent degraded and a further 
magnesium stent was implanted. In spite of the vessel remaining patent surgical repair 
was undertaken at the same time as closure of a ventricular septal defect. 
Progress has also been made in the development of bio-absorbable polymer stents for 
coronary disease. The most common polymer is PLLA or Poly (L-lactic acid) which is 
readily hydrolysed and metabolised (Tamai et al., 2000). The difficulty with polymer 
stents in children is that they require more bulk to achieve the same radial strength as 
metal stents and therefore would require large introducing sheaths.
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Others have opted for a mechanical solution using stents which either separate 
longitudinally or can be fractured allowing implantation of larger stents as the vessel 
grows. The growth stent consists of two stent halves connected by absorbable sutures. 
The stent halves have been demonstrated to separate with growth in animal studies 
(Ewert et al., 2004). Growth stents have also been used in humans in a study of 12 
children aged 1-15 months with coarctation of the aorta, 5 underwent successful 
redilation and 6 successful late overstenting (Ewert et al., 2008). The Osypka baby stent 
is a breakable stent consisting of stainless steel with gold coating which is cut 
longitudinally and then reconnected using surgical sutures (Sigler et al., 2009). With 
growth, redilation allows the stent to be broken and if required further stents to be 
implanted within. As yet there are no reports of the use of this stent in man.
Finally there will need to be more interaction between surgeons and cardiologists to 
develop hybrid therapies to treat congenital stenoses. Already hybrid procedures exist to 
for stage one palliation of hypoplastic left heart syndrome (Galantowicz and Cheatham, 
2005) and new hybrid catheter laboratories are being installed which conform to the 
standards required for cardiac surgery. At the very least the increasing complexity of 
cardiac surgery in very young children will drive the need for hybrid procedures to 
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